State and municipal people’s governments, provincial committees, offices, departments and bureaus:

　　"Yunnan Fuwai Cardiovascular Hospital Comprehensive Reform Pilot Overall Plan" has been approved by the provincial people’s government and is hereby issued to you, please implement it carefully.

　

　

General Office of Yunnan Provincial People’s Government

August 29, 2018

　

　　(This piece is publicly released)

　

Overall scheme of comprehensive reform pilot of Fuwai Cardiovascular Hospital in Yunnan Province

　　In order to promote the reform and development of Fuwai Cardiovascular Hospital in Yunnan Province (hereinafter referred to as Yunnan Fuwai Hospital), we strive to explore a new way of comprehensive reform of public hospitals that is in line with the actual situation in our province, build Yunnan Fuwai Hospital into a world-class high-end medical service center, and make every effort to help our province build a world-class "healthy living destination card".

　　I. Scope of reform

　　This reform pilot was implemented in Fuwai Hospital in Yunnan, which is managed as a public welfare second-class institution.

　　Second, the overall requirements

　　Guided by the Supreme Leader’s Socialism with Chinese characteristics Thought in the New Era, conscientiously implement the spirit of the 19th National Congress of the Communist Party of China, conscientiously deepen the reform and deployment of the medical and health system, follow the basic path of the "three-medical linkage" reform of medical care, medical insurance and medicine, earnestly implement the government’s responsibility for running medical services, give full play to the main role of Yunnan Fuwai Hospital, and try first in exploring and innovating the management system and operation mechanism of public hospitals. Efforts will be made to promote reforms focusing on medical consumables and drug procurement methods, total personnel management, medical insurance payment methods, personnel compensation systems, medical service prices, financial subsidies, etc., and strive to achieve the organic unity of social benefits and operational efficiency, forming a good situation in which the government is at ease, patients are satisfied, and hospitals are healthy and sustainable.

　　III. Objectives and tasks

　　By the end of 2020, we will explore the formation of a relatively perfect modern hospital management system and a new mechanism for maintaining public welfare, mobilizing enthusiasm and ensuring sustainable operation of public hospitals, so as to realize the homogenization of management between Yunnan Fuwai Hospital and China Academy of Medical Sciences, and significantly improve the medical level and service quality. Yunnan Fuwai Hospital has fully opened 12 clinical centers and 27 medical departments for coronary heart disease, hypertension, congenital heart disease and arrhythmia, with 10,000 cases of interventional surgery and 2,500 cases of heart, great vessels and peripheral vascular surgery each year, of which the proportion of third-and fourth-grade operations exceeds 50%, the total service volume and the number of difficult and severe cases in diagnosis and treatment have reached the leading position in China, and the number of new technologies and projects for diagnosis and treatment of cardiovascular diseases has been at the forefront in China, initially covering all. Yunnan Fuwai Hospital will be built into "Yunnan Congenital Heart Disease Screening Management Center" and "Yunnan Cardiovascular Disease Quality Control Center", and gradually become a national regional medical center and clinical medical research center based in Yunnan, facing southwest and radiating South Asia and Southeast Asia.

　　On the basis of accelerating the improvement of clinical discipline construction level and disease prevention ability of Fuwai Hospital in Yunnan, a high-quality cardiovascular disease specialist training base will be basically built, which will be used as a technical support platform to radiate the whole province and promote the continuous improvement of cardiovascular disease treatment ability of hospitals at all levels in the province. By 2020, more than 500 cardiovascular medical professionals will be trained in the province, and the cardiovascular department of 50 county-level hospitals in the province will meet the basic standards of medical service capacity of county hospitals required by the state, and 10 county-level hospitals will meet the recommended standards; Support five state-level hospitals to carry out more than 10 kinds of cardiovascular surgery, and provide technical support for the construction of the province’s cardiovascular chronic disease prevention and control system.

　　Fourth, reform measures

　　(a) to carry out the reform of modern hospital management system. Formulate the Articles of Association of Fuwai Cardiovascular Hospital in Yunnan Province. On the premise of strengthening government supervision and assessment, the relevant departments directly under the provincial government delegated the authority of internal personnel management, department setting, middle-level cadre appointment, internal performance assessment and salary distribution to Fuwai Hospital in Yunnan, giving the hospital full autonomy in operation and management. Strengthen the Party building in Fuwai Hospital of Yunnan in an all-round way, give full play to the leading role of the Party Committee of the hospital, and build the Party organization into a strong fighting fortress. Improve the internal management organization, management system, rules of procedure and procedures of Yunnan Fuwai Hospital, and standardize the internal governance structure and power operation rules.(Responsible unit: Provincial Health and Family Planning Commission, Editorial Office, Human Resources and Social Security Department, Finance Department, Yunnan Fuwai Hospital; The first one is the lead department, the same below)

　　(two) to carry out the reform of medical consumables and drug procurement methods. Yunnan Fuwai Hospital is allowed to be the main body of procurement, directly negotiate prices with high-value medical consumables manufacturers and purchase independently. Take the procurement with quantity and budget, explore the way of cross-regional and specialized hospital joint procurement, and reduce the inflated price of high-value medical consumables. High-value medical consumables are purchased in the high-value medical consumables procurement system of the provincial centralized drug procurement platform, and independent bargaining is carried out offline. The negotiated unit price and total amount are subject to the supervision of relevant departments. According to the reform requirements of Fuwai Hospital in Yunnan, the high-value medical consumables procurement system of the provincial centralized drug procurement platform was developed and reformed individually. In the medical insurance information system, the actual purchase price of Yunnan Fuwai Hospital is protected accordingly. Explore the implementation of the "one-vote system" for the procurement of high-value medical consumables, and Yunnan Fuwai Hospital will directly settle the payment with the production enterprises. According to the procurement method of high-value medical consumables, the procurement reform of suitable drugs and low-value medical consumables will be carried out. For the cases paid according to the project, Yunnan Fuwai Hospital reduces the burden of patients by reducing the high-value medical consumables and the inflated price of drugs.(Responsible units: Provincial Health and Family Planning Commission, Department of Finance, Department of Human Resources and Social Security, Public Resources Trading Administration, Yunnan Fuwai Hospital)

　　(three) to carry out the total personnel management pilot. According to the type characteristics and related factors of Fuwai Hospital in Yunnan, the total number of personnel needed for Fuwai Hospital in Yunnan is determined scientifically and reasonably, and the dynamic adjustment is implemented. Strictly regulate the scope of the total number of personnel, and the personnel within the total number shall be managed according to the staffing of the institution and enjoy the treatment of the personnel of the institution. Simultaneously carry out the pilot reform of government procurement services.(Responsible unit: Provincial Organizing Office, Human Resources and Social Security Department, Finance Department, Health and Family Planning Commission, Yunnan Fuwai Hospital)

　　(four) to carry out the reform of medical insurance payment methods. The reform of medical insurance payment mode will be carried out mainly by grouping payment methods according to disease types and disease diagnosis. Medical insurance agencies at all levels in the province shall pay for the diseases with clear diagnosis and treatment plan and admission criteria and mature diagnosis and treatment technology in Fuwai Hospital, and reasonably determine the payment standard of diseases (disease groups), the proportion of medical insurance payment and the proportion of individual patients’ payment, and implement packaged payment, with the balance retained and the cost overruns not covered. Strive to make the proportion of cases paid by groups according to diseases and disease diagnosis in Yunnan Fuwai Hospital exceed 80% by 2020, and the medical insurance agency will adjust and maintain the settlement method and information system according to the reform needs of Yunnan Fuwai Hospital. The hospital information system of Yunnan Fuwai Hospital is open to medical insurance agencies and audit departments, and is subject to supervision and audit. According to the principle of "scientific, safe, standardized, effective, economical and ethical", the clinical pathway management and quality control work adapted to the functions and tasks of Yunnan Fuwai Hospital should be implemented, and the diagnosis and treatment behavior should be standardized in strict accordance with the diagnosis and treatment routine and technical regulations to ensure medical quality and safety.(Responsible unit: Provincial Department of Human Resources and Social Security, Department of Finance, Health and Family Planning Commission, Yunnan Fuwai Hospital)

　　(five) to carry out the reform of personnel compensation system. Establish a personnel management system that is compatible with the total personnel management. Implement the autonomy of employing people in Yunnan Fuwai Hospital, and allow Yunnan Fuwai Hospital to independently recruit and introduce personnel by means of examination or inspection under the premise of strictly implementing information disclosure, process disclosure and results disclosure. Encourage Fuwai Hospital in Yunnan to introduce outstanding professionals from abroad, and play a good role as a platform to cultivate and improve the level of relevant medical disciplines in the province. Talents who are urgently needed and in short supply from outside the province and have the qualifications of deputy senior and above professional and technical positions or have obtained doctoral degrees can re-establish personnel files after leaving their original units to work in Fuwai Hospital in Yunnan. Fuwai Hospital in Yunnan should change the fixed employees into contract employees, change the identity management into post management, and set up posts according to needs, compete for posts, hire by posts, and set salaries by posts. Formulate specific personnel management systems such as personnel entry and exit, assessment, rewards and punishments within the total amount, and establish an employment mechanism that can enter and exit, and can be promoted and demoted. Boldly innovate the talent incentive mechanism, and high-level talents introduced by Yunnan Fuwai Hospital can enjoy relevant subsidy policies and project support in accordance with regulations.(Responsible unit: Provincial Health and Family Planning Commission, Editorial Office, Human Resources and Social Security Department, Finance Department, Yunnan Fuwai Hospital)

　　In accordance with the requirements of "allowing hospitals to break through the current wage control level of public institutions, allowing medical service income to deduct costs and withdraw funds according to regulations to be mainly used for personnel rewards", we will actively explore the establishment of a salary system that conforms to the characteristics of the medical industry and fully mobilize the enthusiasm, initiative and creativity of medical personnel. Yunnan Fuwai Hospital will be included in the pilot unit of salary system reform of public hospitals in our province, and the corresponding policy inclination will be given when the total performance salary is approved. Support Yunnan Fuwai Hospital to actively explore various distribution methods such as target annual salary system, agreed salary system and project salary system. Explore the implementation of the target annual salary system management for the main person in charge of Yunnan Fuwai Hospital, and the required funds will be uniformly charged from the operating subsidy funds and service purchase funds arranged by the provincial finance, and will not be arranged separately. Encourage medical staff in Fuwai Hospital in Yunnan to strengthen scientific research innovation. If important scientific research achievements and achievements are transformed into clinical diagnosis and treatment standards and technical specifications, holders of scientific research achievements can enjoy 80% of the benefits from the transformation of achievements and promote the transformation of achievements. It is strictly forbidden to link the salary of medical staff with business income and income from medicines, consumables, inspections and tests.(Responsible units: Provincial Department of Human Resources and Social Security, Department of Finance, Health and Family Planning Commission, Science and Technology Department)

　　(six) to carry out the price reform of hospital medical services. Yunnan Fuwai Hospital is allowed to set its own price within the range of no more than 10% on the basis of the current first-class medical service price in our province. For the medical service items with no approved price in our province, if there are existing ones in Fuwai Hospital of China Academy of Medical Sciences, according to the principle of homogeneity and same price, Fuwai Hospital of Yunnan can refer to the medical service price of Fuwai Hospital of China Academy of Medical Sciences. Yunnan Fuwai Hospital’s new medical service project authorizes Yunnan Fuwai Hospital to independently check the trial price. On the basis of establishing and perfecting the clinical pathway management system, we will support Fuwai Hospital in Yunnan to carry out the reform of pricing mode of charging according to diseases and independently formulate charging standards. Yunnan Fuwai Hospital is allowed to carry out special outpatient service within the scope of not exceeding 10% of the total medical service, and the special outpatient service fee is subject to market adjustment. The actual implementation price of Yunnan Fuwai Hospital should be reported to the Provincial Price Bureau, the Health and Family Planning Commission and the Human Resources and Social Security Department for the record within 10 working days before implementation.(Responsible units: Provincial Price Bureau, Health and Family Planning Commission, Human Resources and Social Security Department)

　　(seven) to carry out the reform of financial subsidies. Reform and improve the financial guarantee mode for Fuwai Hospital in Yunnan, explore the establishment of financial support mode suitable for the reform of Fuwai Hospital in Yunnan, and gradually arrange hospital operation subsidy funds by purchasing services to realize the decoupling of financial subsidy funds from staffing. From 2018 to 2021, according to the principle of "full support, fixed subsidy, gradual adjustment and stimulating vitality", the operating subsidy funds of Yunnan Fuwai Hospital will be reasonably arranged; After 2022, according to the quantity and quality of services provided by Fuwai Hospital in Yunnan, the government will approve the funds for purchasing services. The financial subsidy funds are invested in the planned equipment purchase, key discipline development, personnel training, retirees’ expenses in line with national regulations, policy loss subsidies, and government-designated emergency treatment, disaster relief, foreign aid, agriculture support, border support and counterpart support for urban and rural hospitals.(Responsible units: Provincial Department of Finance, Development and Reform Commission, Human Resources and Social Security Department, Health and Family Planning Commission)

　　(eight) to carry out the reform of hospital service model. The Provincial Health and Family Planning Commission delegated the establishment of departments and the management authority of doctors’ practice in Fuwai Hospital of Yunnan. Yunnan Fuwai Hospital can set up its own departments according to the needs of reform and development, and report them to the Provincial Health and Family Planning Commission for the record; Doctors and nurses from Fuwai Hospital of China Academy of Medical Sciences are allowed to practice at Fuwai Hospital in Yunnan and report to the Provincial Health and Family Planning Commission for the record. Fuwai Hospital in Yunnan should strengthen the construction of hospital culture and build a harmonious doctor-patient relationship. Carry out appointment diagnosis and treatment, increase the proportion of appointment diagnosis and treatment services, and vigorously promote appointment diagnosis and treatment by time and centralized appointment inspection. Steadily carry out daytime surgery to shorten the time for patients to wait for hospitalization and surgery. Take patients as the center, promote multidisciplinary diagnosis and treatment mode, and provide "one-stop" diagnosis and treatment service for patients. Innovate emergency services to provide patients with a green channel for medical treatment and integrated comprehensive treatment services. Using Internet technology to continuously optimize the medical service process, and provide patients with convenient services such as appointment, mobile payment, inter-clinic settlement, bedside settlement, medical reminder, result inquiry and information push.(Responsible unit: Provincial Health and Family Planning Commission, Yunnan Fuwai Hospital)

　　V. Safeguards

　　(1) Strengthen organizational leadership. The leading group for the construction, reform and development of Fuwai Cardiovascular Hospital in Yunnan Province and Yunfu International Cardiovascular Hospital should strengthen the overall coordination of the pilot reform of Fuwai Hospital in Yunnan Province.

　　(2) create a good atmosphere. Relevant departments at the provincial level should strengthen the overall situation awareness and sense of responsibility, cooperate with each other and make concerted efforts to form a joint effort and a good atmosphere for fully caring for and supporting the reform and development of Yunnan Fuwai Hospital, and give active support to Yunnan Fuwai Hospital in participating in scientific research projects and achievements declaration in the province, employing graduate students with teachers’ qualifications, and evaluating the first and the best. Other medical and health institutions in the province should strengthen cooperation and exchanges with Fuwai Hospital in Yunnan with a more open and inclusive attitude, and jointly promote the continuous improvement of the diagnosis and treatment capacity of cardiovascular diseases in the province.

　　(3) Strengthen performance appraisal. The Provincial Health and Family Planning Commission should guide Yunnan Fuwai Hospital to formulate performance evaluation methods, establish a public welfare-oriented evaluation system, and effectively strengthen the internal management of the hospital. According to the specialty characteristics of Fuwai Hospital in Yunnan and the requirements of the reform pilot task, the assessment and evaluation indicators are determined scientifically and reasonably, with emphasis on indicators such as the degree of public welfare goal realization, medical quality, cost control, sustainable development, operational performance, social satisfaction and employee recognition. The performance appraisal of Yunnan Fuwai Hospital should be carried out simultaneously with the annual and term target responsibility appraisal of the dean, and the party building work should be carried out simultaneously with the professional work. The assessment results should be linked with financial subsidies, medical insurance payment, total performance salary, salary, appointment and dismissal, rewards and punishments of the dean (secretary), so as to promote the improvement of medical service quality in Yunnan Fuwai Hospital.

　　(4) Strengthen supervision and evaluation. Give full play to the role of monitoring, evaluation and special supervision, timely supervise the implementation of key tasks of Fuwai Hospital in Yunnan, establish and improve the supervision and inspection mechanism and evaluation accountability mechanism, increase supervision and guidance, and focus on matters that are ineffective or slow in progress. The Provincial Health and Family Planning Commission takes the lead in establishing a monitoring and evaluation system, formulating methods for evaluating the effect of hospital reform, regularly monitoring and evaluating the implementation of the pilot reform of Fuwai Hospital in Yunnan and the reform effect, analyzing and studying the difficulties and problems arising in the reform process in a timely manner, and monitoring the reform progress once every six months to form a monitoring report. By the end of 2020, the third party will be organized to evaluate and summarize the reform effect of Fuwai Hospital in Yunnan, and mature and effective experiences will be promoted in due course. Relevant provincial departments should sum up and improve relevant reform policies in time to ensure the continuity of policies and the stable and sustainable development of Fuwai Hospital in Yunnan.

　　Attachment: 1. Pilot Program for the Reform of Medical Consumables and Drug Purchase Mode in Fuwai Cardiovascular Hospital of Yunnan Province

　　　　　2. Yunnan Fuwai Cardiovascular Hospital Staff Total Management Pilot Program

　　　　　3. Yunnan Fuwai Cardiovascular Hospital Medical Insurance Payment Mode and Personnel Compensation System Reform Pilot Program

　　　　　4. Yunnan Fuwai Cardiovascular Hospital Medical Service Price Reform Pilot Program

　　　　　5. Yunnan Fuwai Cardiovascular Hospital Financial Subsidy Reform Pilot Program

　　　　　6. Implementation plan for improving the diagnosis and treatment capacity of Fuwai Cardiovascular Hospital in Yunnan Province

　

Annex 1

Pilot program for the reform of medical consumables and drug procurement mode in Fuwai Cardiovascular Hospital of Yunnan Province

　　In order to promote Yunnan Fuwai Cardiovascular Hospital (hereinafter referred to as Yunnan Fuwai Hospital) to carry out the pilot reform of medical consumables and drug procurement methods, this plan is formulated according to the Overall Plan for Comprehensive Reform Pilot of Yunnan Fuwai Cardiovascular Hospital.

　　I. General requirements

　　In accordance with the general direction and requirements of the reform of public hospitals, adhere to the principles of openness, fairness and justice, strengthen the "three-medicine linkage" of medical care, medical insurance and medicine, encourage Fuwai Hospital in Yunnan to try first, and further reduce the inflated prices of medical consumables and medicines through various procurement methods such as independent procurement, quantity procurement and joint procurement.

　　Yunnan Fuwai Hospital uses business income and its own funds to carry out medical consumables and drugs procurement projects, allowing hospitals to purchase independently, openly selecting distribution enterprises to be responsible for distribution, and linking with medical insurance payment and disease charging policies. Encourage Yunnan Fuwai Hospital to jointly purchase with relevant specialized hospitals across regions, and further improve the participation of hospitals in centralized drug procurement. The procurement projects of medical consumables and drugs carried out by Yunnan Fuwai Hospital with special financial funds are carried out in strict accordance with the provisions and procedures of People’s Republic of China (PRC) Government Procurement Law, People’s Republic of China (PRC) Bidding Law and other laws and regulations.

　　Second, the reform measures

　　(A) the scientific preparation of procurement plans

　　According to the catalogue of medical consumables and drugs used in Fuwai Hospital of China Academy of Medical Sciences, the procurement plan and budget are put forward with reference to not less than 80% of the medical consumables and drugs used in the previous year.

　　(B) to carry out high-value medical consumables procurement reform.

　　1. Purchasing method. On the premise of carrying out the compound payment mode of grouping payment according to disease type and disease diagnosis, and combining various payment methods, Yunnan Fuwai Hospital is allowed to be the main purchasing body, adopt online procurement and offline negotiation on the provincial centralized drug procurement platform, and directly negotiate the purchase price of high-value medical consumables with high-value medical consumables manufacturers, and the negotiated unit price and purchase amount are subject to the supervision of relevant departments. According to the reform requirements of Fuwai Hospital in Yunnan, the high-value medical consumables procurement system of the provincial centralized drug procurement platform was developed and reformed individually. In the medical insurance information system, the actual purchase price of Yunnan Fuwai Hospital is protected accordingly. Yunnan Fuwai Hospital is allowed to explore cross-regional joint procurement with relevant domestic specialized hospitals to ensure that the procurement price is lower than the reference price of the provincial centralized drug procurement platform.

　　2. Distribution management. Yunnan Fuwai Hospital openly selects high-value medical consumables comprehensive service enterprises according to relevant laws and regulations. Comprehensive service enterprises can set up a first-class management warehouse of high-value medical consumables in Fuwai Hospital of Yunnan, and implement zero inventory management to ensure the timely supply and quality safety of high-value medical consumables.

　　(three) to carry out the reform of purchasing methods of drugs and low-value medical consumables.

　　1. Purchasing method. In accordance with the principle of "platform procurement, bargaining with quantity, two-vote system and centralized distribution" and the relevant provisions of the provincial health and family planning commission on classified procurement, Yunnan Fuwai Hospital is allowed to carry out bargaining procurement of drugs and low-value medical consumables with quantity through the provincial centralized drug procurement platform, which will be distributed centrally by distribution enterprises. Belonging to the pricing procurement, the winning bid price announced by the provincial centralized drug procurement platform is the highest price limit, and the method of exchanging price for quantity is adopted, and the quantity procurement is linked with the quantity price; Belonging to bargaining procurement, independent bargaining procurement on the provincial centralized drug procurement platform; For special drugs, such as poisonous drugs, blood products and some new drugs, which are not hung on the procurement platform, they are indeed purchased for the record according to the relevant requirements because of clinical needs.

　　2. Distribution management. According to relevant laws and regulations, Fuwai Hospital of Yunnan Province selected distribution enterprises for drugs and low-value medical consumables to ensure the supply, quality and safety of drugs and low-value medical consumables.

　　(4) Charge management

　　1. Charge for high-value medical consumables. For cases paid by the project, the high-value medical consumables used are charged according to the actual purchase price and the markup rate stipulated in the Interim Measures for the Price Management of Non-profit Medical Services in Yunnan Province. According to the disease, according to the disease diagnosis related group payment cases, the balance retained, cost overruns do not make up.

　　2. Fees for drugs and low-value medical consumables. Drugs are charged according to the winning bid price announced by the provincial centralized drug procurement platform, and the bonus is cancelled. Low-value medical consumables shall be implemented in accordance with the relevant provisions of the price management of medical services in our province. With the further improvement of the national drug price negotiation mechanism, the scope of negotiation varieties is gradually expanded, and the policy convergence with medical insurance management and handling departments is well done.

　　3. Price protection. The list of expenses issued by Yunnan Fuwai Hospital to patients can only list the quantity of drugs and medical consumables used, subtotal and total expenses, and protect the prices of individual categories.

　　(5) Contract management

　　Yunnan Fuwai Hospital signed a distribution service contract with the distribution enterprise. The procurement of high-value medical consumables is subject to the "one-vote system".

　　Third, the job requirements

　　(1) Strengthen supervision. Provincial Health and Family Planning Commission, Public Resources Trading Administration, Food and Drug Administration, Finance Department, Audit Office and other departments should strengthen the supervision and inspection of the procurement, distribution and use of medical consumables and drugs in Yunnan Fuwai Hospital. Information on the purchase and use of medical consumables and drugs in Fuwai Hospital of Yunnan Province should be disclosed to the public in a timely manner and consciously accept social supervision; It is necessary to establish a publicity and interview system, implement prescription comments, give full play to the role of pharmacists in rational drug use, and improve the level of rational use of medical consumables and drugs; It is necessary to strengthen prescription management and ensure that doctors prescribe drugs according to their generic names. Outpatients can choose to buy drugs at Fuwai Hospital or retail pharmacies in Yunnan by prescription. Strictly control the unreasonable increase of medical expenses.

　　(2) Strengthen the prevention and control of integrity risks. Fuwai Hospital in Yunnan should make collective decisions by including medical consumables and drug procurement in the "three majors and one big project"; It is necessary to focus on strengthening the system construction, with the support of modern information technology, to build a clean and honest risk prevention and control system with clear powers and responsibilities, standardized processes, clear risks, effective measures, timely early warning and in line with the characteristics of the health industry, and to establish a long-term working mechanism to control commercial bribery in the field of medical purchase and sale.

　

Annex 2

Pilot Program of Total Staff Management in Fuwai Cardiovascular Hospital of Yunnan Province

　　In order to promote Yunnan Fuwai Cardiovascular Hospital (hereinafter referred to as Yunnan Fuwai Hospital) to carry out the pilot project of total personnel management, this plan is formulated according to the Overall Plan of Comprehensive Reform Pilot of Yunnan Fuwai Cardiovascular Hospital.

　　I. General requirements

　　In accordance with the relevant requirements of deepening the classification reform of public institutions, deepening the reform of "streamline administration, delegate power, strengthen regulation and improve services" and deepening the reform of medical and health system, we should persist in the innovation of system and mechanism, innovate the staffing management of Fuwai Hospital in Yunnan, implement the management of total personnel, and establish an employment mechanism that can enter and exit, and can be promoted and demoted. Adhere to decentralization, fully give Yunnan Fuwai Hospital the autonomy of employing people, and stimulate the endogenous motivation of hospital reform and development. Adhere to the principle of "active, cautious and controllable", steadily push forward the reform pilot work, study and solve the difficulties and problems in the pilot work in time, and accumulate experience and practices.

　　Second, the reform task

　　(1) Scientifically and reasonably verify the total number of personnel. The provincial editorial office, together with the Provincial Health and Family Planning Commission, the Department of Finance and the Department of Human Resources and Social Security, comprehensively considers the characteristics of Yunnan Fuwai Hospital, the actual number of open beds, the service population, the service volume, the personnel structure and the development trend, and scientifically and reasonably determines the total number of personnel needed for Yunnan Fuwai Hospital. The total number of staff in Yunnan Fuwai Hospital is 550 for the first time. The total number of personnel shall be dynamically managed, and in principle, it shall be dynamically adjusted once every two years.

　　(two) the scope and proportion of total personnel management. The personnel included in the total personnel management include: members of the hospital leadership, administrative personnel, professional and technical personnel (doctors, pharmacy, medical technology, nursing and other professional and technical personnel) and the backbone of the workers. Within the approved total number of personnel, the proportion of professional and technical personnel is not less than 90%, and the administrative personnel and workers are not higher than 10%.

　　(3) Establish a personnel management system that is compatible with the total personnel management. In accordance with the relevant requirements of the "streamline administration, delegate power, strengthen regulation and improve services" reform, simplify administration and decentralize power, and fully give Yunnan Fuwai Hospital the autonomy of employing people. According to the staffing management of public institutions, the personnel within the total amount enjoy the corresponding treatment of the staff of public institutions in terms of post employment, professional title evaluation, assessment, rewards and punishments, social insurance, personnel flow, income distribution and retirement benefits. The recruitment staff of Fuwai Hospital in Yunnan should make the recruitment plan and scheme according to the requirements of information disclosure, process disclosure and results disclosure, and after being approved by the Provincial Health and Family Planning Commission and the Provincial Department of Human Resources and Social Security, take the form of examination or investigation to recruit independently; After joining the company, it is qualified by the evaluation of Fuwai Hospital in Yunnan and approved by the Provincial Health and Family Planning Commission and the Provincial Department of Human Resources and Social Security, and can be included in the total personnel management.

　　Fuwai Hospital in Yunnan should establish and improve the employment mechanism of being able to enter and exit, be able to go up and down, formulate the evaluation method, index system and specific personnel management system for the entry and exit of personnel within the total number of personnel, and organize the implementation after being reported to the provincial office, the Department of Finance, the Department of Human Resources and Social Security and the Health and Family Planning Commission for the record.

　　Third, the job requirements

　　(1) Strengthen organizational leadership. The provincial editorial office is responsible for verifying the total number of staff in Yunnan Fuwai Hospital and taking the lead in coordinating and promoting the pilot work; The Provincial Health and Family Planning Commission is responsible for the guidance and supervision of Fuwai Hospital in Yunnan; The Provincial Department of Finance and the Department of Human Resources and Social Security cooperate to do the relevant work. Fuwai Hospital in Yunnan is the main body responsible for the pilot work, so we should earnestly organize and implement it.

　　(2) Steady and orderly progress. Fuwai Hospital in Yunnan should formulate a specific implementation plan and refine the work tasks item by item; It is necessary to strictly implement various policies and regulations, strictly perform work procedures, establish a correct orientation for employing people, and fully mobilize and stimulate the enthusiasm of cadres and workers.

　　(3) Strengthen supervision and guidance. The provincial editorial office shall, jointly with the Provincial Health and Family Planning Commission, the Department of Finance and the Department of Human Resources and Social Security, strengthen supervision and guidance on the pilot work, closely follow the progress of the pilot work, study and solve problems in the work in a timely manner, and sum up experiences and practices.

　

Annex 3

Pilot scheme of medical insurance payment method and personnel salary system reform in Fuwai Cardiovascular Hospital of Yunnan Province

　　In order to promote Fuwai Cardiovascular Hospital of Yunnan Province (hereinafter referred to as Yunnan Fuwai Hospital) to carry out the pilot reform of medical insurance payment method and personnel compensation system, this scheme is formulated according to the Overall Plan for Comprehensive Reform Pilot of Fuwai Cardiovascular Hospital of Yunnan Province.

　　I. General requirements

　　Focusing on the goal of deepening the reform of medical and health system, we will explore the establishment of medical insurance payment methods that conform to the actual situation and medical service characteristics of Fuwai Hospital in Yunnan, and stimulate the endogenous motivation of hospitals to standardize diagnosis and treatment behavior, control costs, and reasonably treat and refer patients; Explore the establishment of a flexible and efficient personnel management system that is compatible with the total personnel management; According to the requirements of "allowing hospitals to break through the current wage control level of public institutions, allowing medical service income to deduct costs, and then withdrawing various funds according to regulations, we will explore the establishment of a salary distribution system that conforms to the actual situation of Fuwai Hospital in Yunnan, and strive to reflect the value of medical staff’s knowledge, technology and labor, mobilize the enthusiasm of medical staff, enhance the public welfare of the hospital, and promote the healthy development of Fuwai Hospital in Yunnan.

　　Second, the reform task

　　(A) to carry out medical insurance payment reform pilot.

　　1. The implementation of multiple compound medical insurance payment methods based on disease types and disease diagnosis related groups. According to the characteristics of medical services in Fuwai Hospital in Yunnan, for diseases with clear diagnosis, clear diagnosis and treatment path and mature diagnosis and treatment technology, payment is implemented according to the disease type and related groups of disease diagnosis. For complex cases that cannot be settled by disease type and disease diagnosis, they shall be paid according to the project. All kinds of payment methods implemented by Fuwai Hospital of China Academy of Medical Sciences and outside the province can be supported in time in combination with the actual situation in our province. By 2020, Yunnan Fuwai Hospital will make the proportion of cases that are paid according to diseases and diseases diagnosis more than 80%, and medical insurance agencies will adjust and maintain the settlement methods and information systems according to the needs of hospital reform. Establish and improve the equal consultation mechanism between medical insurance agencies and Yunnan Fuwai Hospital, and the incentive and risk sharing mechanism of "balance retention and reasonable cost overruns sharing".

　　2. Support Yunnan Fuwai Hospital to develop new technologies and projects. The provincial human resources and social security department timely studied and formulated the medical insurance payment policy to support the new technologies and new projects carried out by Fuwai Hospital in Yunnan.

　　(B) to carry out the personnel management system reform pilot.

　　1. Decentralize the right to evaluate professional titles. The right to evaluate the deputy senior title of health technology was delegated to Yunnan Fuwai Hospital, which independently evaluated the qualification of the deputy senior title of health technicians in our hospital in accordance with the national and provincial professional and technical title evaluation procedures and relevant management regulations.

　　2. For foreign high-level experts and young doctors under 40 years old who are mainly introduced from Fuwai Hospital in Yunnan Province, if they are selected as "high-end foreign experts" and "special young talents" in Yunnan Province’s Thousand Talents Program after evaluation, they will be given a one-time working and living allowance of 500,000 yuan and a maximum project funding of 1 million yuan.

　　3. The high-level talents introduced by Fuwai Hospital in Yunnan Province are in urgent need of shortage in our province. Upon the assessment of the Provincial Department of Human Resources and Social Security, they are given 500,000 yuan, 300,000 yuan and 200,000 yuan housing subsidies and 100,000 yuan, 70,000 yuan and 50,000 yuan working funds respectively, and actively do a good job in introducing talents.

　　4. Timely apply for the "Green Channel Service Certificate for Introducing High-level Talents in Yunnan Province" for talents who meet the prescribed conditions introduced by Yunnan Fuwai Hospital, and enjoy corresponding services in accordance with the regulations.

　　(C) to carry out the pilot reform of the salary system

　　1. Yunnan Fuwai Hospital will be included in the pilot reform of salary system of public hospitals in our province. Yunnan Fuwai Hospital is allowed to break through the current wage control level of public institutions, allowing medical service income to deduct costs and withdraw various funds according to regulations, which are mainly used for personnel rewards.

　　2. Tilt the relevant salary policy. Yunnan Fuwai Hospital is allowed to establish a salary system that adapts to the characteristics of the hospital in accordance with the Implementation Opinions of the Provincial Department of Human Resources and Social Security, the Department of Finance, and the Health and Family Planning Commission (Yun Ren She Fa [2017] No.96). The Provincial Department of Human Resources and Social Security gives corresponding policy inclination when approving the total amount of performance pay.

　　3. Give internal distribution autonomy. Give Yunnan Fuwai Hospital autonomy in performance appraisal and internal distribution, focusing on key positions and high-level talents, focusing on reflecting the value of medical staff’s technical services and mobilizing the enthusiasm of medical staff.

　　Third, the job requirements

　　(1) Strengthen organizational leadership. Relevant departments directly under the provincial government should closely cooperate and coordinate to promote reform, properly link up policies and give full play to policy synergy; It is necessary to carry out the evaluation of the reform effect in time to provide support for the reform and improvement of the province’s medical insurance payment method and personnel compensation system.

　　(2) Strengthen internal management. Fuwai Hospital in Yunnan should establish and improve the internal management system matching with the reform pilot, make full use of the role of medical insurance in regulating, guiding, supervising and restricting medical service behavior and expenses, strengthen the management of medical personnel, actively control costs and expenses, and improve the efficiency of the use of medical insurance funds. On the basis of the approved total number of personnel, exercise the autonomy of hospital personnel management and salary distribution according to the law and regulations.

　　(3) Strengthen supervision and management. Provincial departments should strengthen the supervision and management of medical service behavior, personnel management and salary distribution of Fuwai Hospital in Yunnan. The medical insurance management department should strengthen the management of medical insurance service agreement, improve the medical insurance information system, improve the scientific and reasonable assessment system, strengthen the dual control of medical expenses and medical quality, and link the assessment results with the medical insurance fund payment.

　

Annex 4

Pilot scheme of medical service price reform in Fuwai Cardiovascular Hospital of Yunnan Province

　　In order to promote Fuwai Cardiovascular Hospital of Yunnan Province (hereinafter referred to as Yunnan Fuwai Hospital) to carry out the pilot reform of medical service price, this scheme is formulated according to the Overall Plan for Comprehensive Reform Pilot of Fuwai Cardiovascular Hospital of Yunnan Province.

　　I. General requirements

　　Actively and steadily push forward the reform of the pricing mode of medical services in Fuwai Hospital in Yunnan, do a good job in linking the price of medical services with policies such as medical care, medical insurance and medicine, and gradually establish a scientific, reasonable, dynamic adjustment and multi-participation medical service price formation mechanism to ensure the sustainable operation of Fuwai Hospital in Yunnan, the affordability of medical insurance funds and the overall burden of the masses.

　　Second, the reform task

　　(1) Yunnan Fuwai Hospital is allowed to set its own price within the range of no more than 10% on the basis of the current price of first-class medical services in our province.

　　(II) For the medical service items with no approved price in our province, if the Fuwai Hospital of China Academy of Medical Sciences already exists, according to the principle of homogeneity and the same price, Fuwai Hospital of Yunnan can refer to the medical service price of Fuwai Hospital of China Academy of Medical Sciences.

　　(three) the new medical service projects carried out by Fuwai Hospital in Yunnan Province shall be independently approved by the hospital for trial price.

　　(4) For the diseases that have not been charged by diseases in our province at present, on the basis of establishing and perfecting the clinical pathway management system, support Yunnan Fuwai Hospital to carry out the reform of charging by diseases and independently formulate charging standards.

　　(5) In order to meet patients’ medical service needs at different levels, Yunnan Fuwai Hospital is allowed to carry out special outpatient service within the scope of not exceeding 10% of the total medical service, and the special outpatient service fee is subject to market adjustment.

　　Third, the job requirements

　　(1) Strengthen guidance and supervision. The Provincial Price Bureau, the Health and Family Planning Commission, and the Human Resources and Social Security Department should closely cooperate and cooperate with each other, strengthen the guidance and supervision of the reform of medical service price in Fuwai Hospital in Yunnan, make overall consideration of the interests of all parties, and do a good job in the convergence of policies such as medical service price, medical insurance and fee control; It is necessary to guide Yunnan Fuwai Hospital to establish and improve the internal price management system, implement the system of clearly marked price and detailed list of medical expenses, and create an honest medical unit.

　　(2) Do a good job in monitoring and evaluation. The Provincial Price Bureau, the Health and Family Planning Commission, and the Human Resources and Social Security Department should pay close attention to the situation after the reform of medical service prices to prevent the relevant supporting policies from being in place, resulting in an increase in the burden on hospitals or patients; It is necessary to strengthen the evaluation of the reform situation and effect, and timely adjust and improve the reform policy.

　　(3) Strengthen support for reform. Fuwai Hospital in Yunnan should scientifically calculate the cost of medical services and diseases, and provide scientific data support and reference for setting prices; It is necessary to bring cost accounting, price management and patient burden into the hospital performance appraisal system, and mobilize the enthusiasm of medical staff and management personnel to control fees; It is necessary to publicize the service items, prices and charging basis, supervision and reporting telephone numbers and other contents to the society in a prominent position.

　　(4) Standardize the price adjustment behavior. For medical services that are subject to market adjustment and independently set prices, Yunnan Fuwai Hospital reasonably sets prices according to service costs and market conditions and keeps them relatively stable, and the price adjustment period shall not be less than one year. The actual implementation price of Yunnan Fuwai Hospital should be reported to the Provincial Price Bureau, the Health and Family Planning Commission and the Human Resources and Social Security Department for the record within 10 working days before implementation.

　

Annex 5

Pilot program of financial subsidy reform in Fuwai Cardiovascular Hospital of Yunnan Province

　　In order to promote Fuwai Cardiovascular Hospital of Yunnan Province (hereinafter referred to as Fuwai Hospital of Yunnan Province) to carry out the pilot reform of financial subsidies, this plan is formulated according to the Overall Plan for Comprehensive Reform of Fuwai Cardiovascular Hospital of Yunnan Province.

　　I. General requirements

　　Adhere to the public welfare nature of public hospitals, reform and improve the way public finance supports public hospitals, establish a scientific and reasonable financial guarantee and compensation mechanism, and promote the formation of a new mechanism for hospital operation that is conducive to maintaining public welfare, mobilizing enthusiasm and ensuring sustainability.

　　Second, the reform task

　　(1) Arrangement of subsidy funds

　　From 2018 to 2021, Yunnan Fuwai Hospital will be subsidized by means of fixed subsidy and gradual adjustment. Among them, 70 million yuan will be allocated for operation subsidy in 2018, 70 million yuan in 2019, 60 million yuan in 2020 and 50 million yuan in 2021.

　　After 2021, in accordance with the requirements of government procurement service reform of public institutions and referring to the security policies of other provincial public hospitals, Yunnan Fuwai Hospital will be subsidized.

　　(2) Ways of financial subsidies

　　In 2018, the transitional financial subsidy policy was implemented, and the financial funds were directly allocated to Yunnan Fuwai Hospital. Starting from 2019, we will implement the reform of financial support mode based on government purchasing services, and arrange the financial subsidy funds of Yunnan Fuwai Hospital to be included in the departmental budget of the Provincial Health and Family Planning Commission for protection. As the main body of government purchasing services, the Provincial Health and Family Planning Commission will include the subsidy funds in the departmental budget of the Provincial Health and Family Planning Commission in the form of government purchasing services, and report them to the Provincial Department of Finance for review, and sign a government purchasing service contract with Yunnan Fuwai Hospital in accordance with the relevant provisions on government purchasing services, and pay them according to the contract.

　　Third, the job requirements

　　(1) Strengthen policy implementation. The Provincial Department of Finance earnestly implemented the financial subsidy policy for Fuwai Hospital in Yunnan. The Provincial Health and Family Planning Commission studied and formulated a specific implementation plan for the reform of government procurement services in Fuwai Hospital in Yunnan.

　　(2) Improve financial management. All revenues and expenditures of Yunnan Fuwai Hospital are included in the budget management, and the relevant provisions of the financial system and accounting system are strictly implemented. The Provincial Department of Finance strengthens the overall budget and financial management of Fuwai Hospital in Yunnan, and organizes the annual financial report audit of the hospital in conjunction with the Provincial Health and Family Planning Commission to promote the steady and healthy development of the hospital.

　　(3) Strengthen performance appraisal. The Provincial Department of Finance, together with the Provincial Health and Family Planning Commission and other departments, explored the third-party performance evaluation of government-purchased services in Fuwai Hospital of Yunnan Province, and established an incentive and restraint mechanism linking the assessment results with the subsidy funds. The evaluation results served as an important reference for the payment of service purchase funds and the selection of service purchase projects, and effectively improved the efficiency in the use of financial funds.

　

Annex 6

Implementation plan of improving diagnosis and treatment ability of Fuwai Cardiovascular Hospital in Yunnan Province

　　In order to further improve the diagnosis and treatment ability and level of Fuwai Cardiovascular Hospital in Yunnan Province (hereinafter referred to as Yunnan Fuwai Hospital), this plan is formulated according to the Overall Plan for Comprehensive Reform of Fuwai Cardiovascular Hospital in Yunnan Province.

　　I. General requirements

　　Relying on the support of the medical management level and technical force of Fuwai Hospital of China Academy of Medical Sciences (hereinafter referred to as Fuwai Hospital of the Academy of Medical Sciences), we will gradually improve the diagnosis and treatment ability and level of Fuwai Hospital. Yunnan Fuwai Hospital has fully opened its clinical center and medical technology department, and its discipline construction has reached the requirements of the national evaluation standard for key clinical specialties. It has basically built a high-quality cardiovascular disease specialist training system, which is used as a technical support platform to radiate the whole province, promote the continuous improvement of cardiovascular disease treatment ability of hospitals at all levels in the province, provide technical support for the construction of the prevention and control system for cardiovascular chronic diseases in the province, and realize the objectives and tasks set in the Overall Plan for Comprehensive Reform of Cardiovascular Hospital in Fuwai, Yunnan Province.

　　Second, the main measures

　　(1) Homogenized introduction of advanced medical technology from Fuwai Hospital of Chinese Academy of Medical Sciences

　　1. Homogenization and introduction of hospital information system. Fuwai Hospital of Yunnan adopts the core information system independently developed by Fuwai Hospital of Chinese Academy of Medical Sciences to ensure the seamless connection of information between Fuwai Hospital of Yunnan and Fuwai Hospital of Chinese Academy of Medical Sciences, and the core information system is homologous and homogeneous. Establish a closed-loop information solution with hospital information system and electronic medical record system as the core, highly integrated image archiving and transmission system, laboratory information system and other whole processes, covering different fields such as medical treatment, teaching, scientific research and disease prevention and control.

　　2. Give full play to the leading role of experts stationed in Fuwai Hospital of Chinese Academy of Medical Sciences. Relying on the long-term team of doctors, technicians, nursing and management experts stationed in Fuwai Hospital of the Academy of Medical Sciences, we will accelerate the formation of an expert group integrating medical treatment, teaching, scientific research, personnel training and international cooperation, and lead the development of cardiovascular disease diagnosis and treatment in the province.

　　3. Actively carry out academic exchange activities at home and abroad. Fuwai Hospital of Chinese Academy of Medical Sciences sent first-class experts to Yunnan to carry out academic exchange activities. Fuwai Hospital of Yunnan actively undertakes academic exchange activities at home and abroad, such as the International Complex Congenital Heart Disease Summit Forum, Kunming International Cardiovascular Disease Forum, Fuwai Aortic Disease Treatment Seminar, the latest progress seminar of interventional therapy for cardiovascular diseases, and the "Heart Pacing in 100 Counties", so as to enhance the diagnosis and treatment ability of cardiovascular diseases in Yunnan and effectively play the role of radiation to drive and lead the demonstration.

　　(B) to strengthen the construction of talent team

　　Arrange all young and middle-aged doctors, technicians and nursing staff in Fuwai Hospital of Yunnan to go to Fuwai Hospital of Chinese Academy of Medical Sciences for standardized training in cardiovascular diseases. Fuwai Hospital in Yunnan adopts various forms, such as young doctors’ growth tutorial system, applying for a master’s degree with the same academic level, and circulating training for further professional study, to give full play to the role of experts in the hospital, to improve the overall quality of medical staff, to build a team of professional and technical personnel with both morality and skills, and to gradually make the academic qualifications, professional titles and age structure of the professional personnel more reasonable and perfect. Relying on the brand advantage of Fuwai Hospital of Chinese Academy of Medical Sciences, talents with associate senior and above professional and technical post qualifications or doctor’s degrees that are urgently needed in hospitals are introduced from outside the province, and personnel files can be re-established after leaving their original units to work in Fuwai Hospital of Yunnan. Fuwai Hospital of Yunnan creates favorable conditions for introducing talents.

　　(C) to strengthen medical quality control

　　Fuwai Hospital in Yunnan should standardize the diagnosis and treatment process according to the requirements of the national cardiovascular disease quality control index system, ensure that the diagnosis and treatment process meets the quality control requirements, effectively reduce the surgical mortality and infection rate, and ensure the homogeneity of hospital medical quality with Fuwai Hospital of Chinese Academy of Medical Sciences. Yunnan Fuwai Hospital should take the lead in establishing quality control indicators of cardiovascular diseases in Yunnan Province in accordance with the requirements of the Provincial Health and Family Planning Commission, and guide relevant medical institutions in the province to standardize the diagnosis and treatment of cardiovascular diseases.

　　(D) to strengthen the guidance and assistance to the grassroots.

　　1. Regularly send experts to primary hospitals to guide the work. Establish a cardiovascular disease specialist alliance with the participation of provincial, prefecture and county hospitals. Through the establishment of "Yunfu Clinic", ward rounds, surgical teaching, etc., directly participate in the clinical work of primary hospitals, and rapidly improve the diagnosis and treatment ability of cardiovascular diseases in primary hospitals. Fuwai Hospital in Yunnan should regularly organize experts to help primary hospitals, and send at least 5 experts with deputy senior titles or above to guide medical activities in cities, counties and hospitals every month for no less than 2 days.

　　2. Regular teaching and on-site training for primary hospitals. Set up a "Yunfu Lecture Hall", formulate personalized training programs according to the needs of primary hospitals and doctors, and strive to improve the standardization of diagnosis and treatment in primary hospitals. Establish a long-term cooperation mechanism with grassroots hospitals to open a "green channel" for people in remote areas to see a doctor. Give priority to the procedures of hospitalization, discharge, and application for special hardship fund for referral patients in primary hospitals, and apply for charitable fund for poor children with congenital heart disease.

　　3. Implement the "Yunyan Plan". Support cardiovascular internal medicine and surgeons from hospitals at or above the county level to go to Fuwai Hospital in Yunnan for standardized training in cardiovascular diseases. According to the needs of the grassroots, short-term (1-3 months), medium-term (3-6 months) and long-term (12 months) training programs are offered for key physicians of different levels, different seniority and different sub-professional directions.

　　4. Improve the scientific research level of primary hospitals. Relying on the scientific research platform of Fuwai Hospital of Chinese Academy of Medical Sciences and Fuwai Hospital of Yunnan Province, we will set up horizontal scientific research projects, absorb the staff of grass-roots hospitals to participate in the research of scientific research projects, and improve the scientific research ability.

　　5. Establish a telemedicine service network. Relying on Fuwai Hospital of Chinese Academy of Medical Sciences and Yunnan Fuwai Hospital as the fulcrum, we will integrate the telemedicine network resources of tertiary hospitals, county hospitals and township hospitals in the province, and further develop the information platform and remote grading diagnosis and treatment network of Yunnan Cardiovascular Disease Diagnosis and Treatment Center. Establish a large database of cardiovascular disease prevention and control in Yunnan Province to improve the ability of cardiovascular disease prevention and control at the grassroots level.

　　Third, the job requirements

　　(1) Strengthen organization and implementation. Fuwai Hospital in Yunnan should refine the work tasks item by item, define the time schedule, and earnestly organize the implementation.

　　(2) Strengthen supervision and inspection. The Provincial Health and Family Planning Commission should strengthen the guidance, inspection and supervision of Fuwai Hospital in Yunnan, and regularly carry out monitoring and evaluation to ensure the effectiveness of the work.

One,

　

Let’s imagine a scene: you spent hundreds of thousands of dollars on a car, and after a few months, the sales came to chase after it and said, I’m sorry, you bought a low-priced car, but we mistakenly asked you to take a high-priced car, so we need to dismantle those configurations in your car that can only be enjoyed by high-priced cars.

　

What the Fxxx？ ! Do you think you are a fool as a consumer or admit that you are a fool?

　

　

You must think that this might only appear in a funny joke, then I can only say that you are naive. Because I did this kind of thing once recently.

　

Recently, according to foreign media reports, it was announced that the software of some delivered vehicles would be downgraded, because the company was equipped with a standard Plus version with a price of nearly $40,000 on the standard version they had sold for $35,000. After this situation, consumers were told in a hurry that they needed to withdraw this part of functions and configurations.

　

Second,

　

There is a need to popularize science here: there are some differences between our cars and the tradition. Some models of different versions are only different in software settings and almost identical in hardware configuration. Therefore, only by downgrading the software, some vehicle configurations including battery life can be adjusted. To put it bluntly, the configuration of the models they sell is wrong, so you can change your configuration directly through the system software.

　

　

This sounds like a very simple thing. Sales don’t have to "disassemble" your configuration, and the system can be remotely controlled. However, have car companies ever taken into account the violent attacks suffered by consumers?

　

There is no problem when buying a car, no problem when picking it up, and even the car that has been used for a while is still no problem. Then you informed me that "I’m sorry that your money suddenly didn’t pay enough, and we will downgrade it online for you"!

　

In my opinion, the only problem is that there is something wrong with our service. It is better to say that we are not focused enough than professional enough.At least, in the sales process of many traditional car companies, I have never heard of such a thing as paying low-priced money but selling high-priced cars by mistake.

　

　

Third,

　

According to the e-mail sent to some consumers who bought the standard model, "Your computer will soon receive the new software that matches the configuration of the standard model you ordered. As we communicated in April, this included a limited battery life of 220 miles (about 350 kilometers) and cancelled some software functions. To continue to experience the extended battery life, faster acceleration and autopilot functions of the standard Plus version, please arrange a service appointment through the application. "

　

According to this statement, these car owners can upgrade their configuration by adding money later.

　

Do you feel the same as me when you see this?This TM is not a marketing routine played by Tesla!

　

　

Pretend not to know, wait for the owner to get used to the high configuration, and then tell you that we are sorry that we made a mistake and will help you downgrade. If you want to continue to experience the high configuration, you can make a new appointment, dear! Maybe many car owners will think that they are used to high configuration, so add money and don’t want to be downgraded.

　

Of course, I must emphasize that the above paragraph is only my guess, but it is difficult for such a service accident to make consumers not have similar ideas. Not only that, the official price cut earlier, and then the basic assisted driving function was given, and the change from time to time made the car owners very headache.

　

Perhaps Tesla’s technology is awesome and the car is really smart enough, but please be more professional in sales and service. Don’t treat all consumers as fools. Such a "sales accident" either makes consumers suspect that there is something wrong with your system, or makes consumers suspect that your marketing has a routine.

　

Neither is a good thing.

　

Finally, consumers in the China market don’t need to worry, because the standard version has not been sold to the China market, and there are no cars yet, so any marketing routine can’t be yours for the time being.

　

　

　

　

In recent years, online lending has become a means for many people to solve the shortage of funds. However, due to high interest rates, complicated terms and repayment pressure, borrowers may face the dilemma of overdue repayment, which has led to the emergence of legal documents-lawyers’ letters. Then, how long will it take for the online loan to send a lawyer’s letter to be sued? This question affects the nerves of countless people. This website will start with "How long will it take to send a lawyer’s letter to the online loan to be prosecuted", and comprehensively analyze the relevant questions to help readers understand the relevant legal procedures and countermeasures.

We need to know what a lawyer’s letter is. A lawyer’s letter is a written notice sent by a lawyer to the debtor in the name of a lawyer entrusted by the client (usually a creditor or an online lending platform) to urge the debtor to fulfill relevant obligations. For the online lending platform, the main purpose of sending a lawyer’s letter is to remind the borrower to repay the loan as soon as possible and avoid further legal means, such as prosecution.

Then, how long will it take for the online loan to send a lawyer’s letter to be sued? The lawyer’s letter is not the beginning of prosecution in essence, but an "ultimatum" issued by the online lending platform. If the borrower fails to repay the loan within the time specified in the lawyer’s letter, the online lending platform reserves the right to further legal prosecution. How long it will take to be prosecuted actually depends on many factors, such as the operation mode of the platform and the complexity of the case.

Many people will panic after receiving a letter from a lawyer, fearing that they will be prosecuted immediately. Sending a lawyer’s letter on an online loan does not mean that the borrower will be sued immediately. The platform usually tries to communicate with the borrower by lawyer’s letter first, so as to try to solve the loan problem as soon as possible.

Then, how long will it take for the online loan to send a lawyer’s letter to be sued? It needs to be clear that the lawyer’s letter is essentially just a legal notice and does not have compulsory execution. It is more of a warning in advance, making borrowers aware of the possible legal consequences. However, the repayment period is usually stated in the lawyer’s letter. For example, the borrower is required to pay off the debt within a few days after receiving the letter, otherwise the platform may take further legal action.

There is no fixed time point for the specific "how long it will be prosecuted". Some online lending platforms may push for prosecution 714 days after the lawyer’s letter is issued, while others may take months or even longer to take legal action. This is often related to the overdue amount, the borrower’s economic situation and the internal decision-making speed of the platform.

How long will it take for an online loan to send a lawyer’s letter to be prosecuted? This question is not only a procedural question, but also involves the legal basis.

According to Chinese laws, creditors (here is the online lending platform) have the right to sue in court to safeguard their rights and interests in debt disputes. Usually, the limitation of action for recourse of creditor’s rights is three years, that is to say, as long as the lawsuit is filed within three years, the court will accept it. Online lending institutions reduce the risk of capital flow, and usually do not delay to the limit of the statute of limitations, but will take action against malicious arrears as soon as possible.

Lawyer’s letter mainly plays the role of urging repayment, which has formal legal meaning, but in fact it has no direct legal force. As long as the overdue behavior is not effectively controlled, the online lending platform will evaluate whether to sue immediately or gain time for internal mediation according to the actual situation after issuing a lawyer’s letter.

It should be noted that different online lending platforms have their own internal regulations on the time to take legal action, but when the amount of arrears is large, the platform usually speeds up the process. Borrowers should negotiate with the platform as soon as possible, instead of passively avoiding it, so as not to quickly enter the prosecution stage due to delay.

Many borrowers choose to ignore or even ignore lawyers’ letters, which is very unwise. If you choose not to deal with it, the consequences may be very serious. Then, how long will it take for the online loan to send a lawyer’s letter to be prosecuted and what are the risks after it is not handled?

If the debtor fails to repay the loan according to the time specified in the lawyer’s letter, the online lending platform has the full right to submit it to the court for prosecution to safeguard its legitimate rights and interests. Once accepted by the general court, the debtor will face a series of troubles such as legal summons, trial and enforcement after losing the case.

Failure to deal with the lawyer’s letter may lead to the borrower being recorded with bad credit information, and then entering the "list of untrustworthy executors". If the amount owed is large and is not returned, the court may also implement measures such as freezing bank accounts and sealing up property after the judgment, which will greatly affect the borrower’s life.

In the face of a lawyer’s letter, the borrower should try his best to negotiate with the online lending platform instead of letting the situation deteriorate further. Otherwise, the time for prosecution after the online loan sends a lawyer’s letter may be greatly shortened, and creditors will actively promote the proceedings.

If you receive a letter from an online loan lawyer, the borrower should remain calm and actively face the question, rather than blindly delaying or evading. Specifically, we can take the following measures to avoid entering the prosecution stage quickly.

Actively communicate with online lending institutions.

After receiving the lawyer’s letter, the borrower should get in touch with the online loan platform as soon as possible, express his willingness to repay, and strive for a grace period or negotiate to extend the repayment period. Some platforms may agree to reach an installment repayment agreement to temporarily ease the financial pressure.

Review whether the terms of the contract are legal

The borrower can carefully check the original online loan contract, especially the interest rate clause. If the interest rate is found to be beyond the legal range (usually the annual interest rate shall not exceed 24% to 36%), you can claim to the court to reduce unreasonable repayment through legal channels.

Seek legal help

If there are threatening statements or bad practices in the lawyer’s letter, the borrower can invite the lawyer to intervene to help negotiate and avoid being disturbed by false collection. Lawyers can also evaluate the legal effect of lawyers’ letters and provide help for further litigation.

There is no uniform standard for how long it will take to issue a lawyer’s letter to an online loan, but borrowers should respond to such incidents with a positive attitude to avoid pushing the question to the litigation stage and increasing the processing cost and pressure.

The specific answer to "How long will it take for online loans to send lawyers’ letters to be prosecuted" is not fixed, and the influencing factors include the operation mode of online lending platform, the repayment attitude of borrowers and the complexity of the case itself. Lawyer’s letter is a prelude to legal action, not the formal beginning of legal procedure. After receiving the lawyer’s letter, the debtor still has the opportunity to negotiate repayment to avoid prosecution, but if the time limit given in the lawyer’s letter is ignored, the lawsuit may start soon.

Borrowers should also realize that not paying back on time will not only face prosecution, but also have a huge negative impact on their credit history, life and property. Active communication and legal handling are the correct ways to solve online loan disputes. No matter how complicated things are, escaping is not the solution.

　　Recently, the market supervision departments in many places issued a notice on the unqualified food sampling list. The Paper combed and found that it involved many problems such as pesticide residues and microbial pollution. The market supervision department has carried out verification and disposal work.

　　It is noteworthy that coliforms were detected in tableware and rice noodles in the unqualified sampling list of several batches of food published by Tai ‘an Municipal Market Supervision Administration and Baise Municipal Market Supervision Administration.

　　Why are coliforms detected in tableware and rice noodles? Kai Zhong, deputy director of Kexin Food and Nutrition Information Exchange Center, said that coliforms mainly come from the intestines of warm-blooded animals, but they are widely distributed in nature. Dishes, rice noodles and so on have coliforms exceeding the standard, mostly because of secondary pollution.

　　Many enterprises were found to contain coliforms in their products.

　　On July 5th, Tai ‘an Municipal Market Supervision Administration issued the information circular on food safety sampling inspection (hereinafter referred to as the circular), which disclosed problems such as excessive pesticide residues and microbial pollution.

　　According to the notice, coliforms were detected in the tableware plates of Fuchunyuan Restaurant in Taishan District and Shandong Xiaolongxiao Jiutian Catering Management Co., Ltd. in Taishan District. According to the national food safety standards, coliforms should not be detected in tableware.

　　Tai ‘an Municipal Market Supervision Administration said in the notice that the market supervision department of the place where the production and operation enterprises are located has ordered the enterprises to find out the product flow, recall and remove the unqualified products, control risks, file an investigation, and analyze the reasons for rectification. The unqualified products involved have been verified and disposed of as required.

　　The Paper combed and found that Baise Municipal Market Supervision Administration had previously released the 26th food safety supervision and sampling information announcement in 2021 on July 1, which also showed that the prepared fresh and wet rice noodles sold by Guangxi Tiandong Weimeijia Agricultural Products Development Co., Ltd. and tianlin county Huaxu Food Co., Ltd. were all found to have coliforms.

　　Kai Zhong, deputy director of Kexin Food and Nutrition Information Exchange Center, said that coliforms are the general name of many bacteria, including Escherichia coli. It is a hygienic indicator bacterium, but it does not lead to disease if it is detected. The higher the detection value, the greater the possibility. Coliform bacteria can be detected in many foods, but as long as there are no pathogenic bacteria, it will generally not cause health hazards. As for the source of coliform bacteria, Kai Zhong said that coliform bacteria mainly come from the intestines of warm-blooded animals, but they are widely distributed in nature. Dishes, rice noodles and so on have coliform bacteria exceeding the standard, mostly because of secondary pollution.

　　According to the interpretation information released by the market supervision department, coliform bacteria is one of the commonly used indicator bacteria for food pollution at home and abroad. The detection of coliform bacteria in food suggests that it is more likely to be contaminated by pathogenic bacteria (such as Salmonella, Shigella and pathogenic Escherichia coli). Excessive coliform bacteria may be caused by the pollution of processing raw materials and packaging materials of products, or the pollution of products by production equipment and environment such as personnel and tools during production, and the incomplete sterilization of products with sterilization technology.

　　A variety of foods were found to have excessive drug residues.

　　In addition to coliform bacteria, some enterprises have been found to have drug residues and other problems. In the notice issued by Tai ‘an Municipal Market Supervision Administration on July 5, the bureau disclosed that the content of "procymidone" in leeks sold by Baxianju Commercial Bank in Ningyang County and Yanzhuang Haiwei Supermarket in Daiyue District was higher than the national food safety standard.

　　The Paper combed and found that in recent food sampling notices issued by many market supervision administrations, the problem of unqualified drug residue detection of enterprise-related products appeared.

　　On July 2nd, the 7th notice of Gansu Provincial Market Supervision Bureau on the sampling inspection of unqualified food showed that chloramphenicol, a drug banned from food animals, appeared in Jinghui brand acacia honey produced by Gansu Jinghui Bee Industry Co., Ltd..

　　On July 5, 2021, Jilin Provincial Market Supervision and Management Department’s 27th notice on unqualified food showed that the carp sold by Fengyun Aquatic Products Company in Automobile Industry Development Zone, Wuchang Fish sold by Yixin Aquatic Products Store in Chaoyang District and snakehead sold by Guo Di Seafood Wholesale Company in Kuancheng Agricultural Products and Aquatic Products Market were all found to exceed the standard.

　　The attachments of the above-mentioned relevant notices show that excessive coliforms are likely to cause intestinal diseases such as dysentery, which may cause symptoms such as vomiting and diarrhea. The pesticide procymidone is irritating to people’s eyes and skin. Long-term consumption of leeks with excessive procymidone residues may cause neurological disorders.

　　The market supervision department reminds consumers that when they find the unqualified products involved in the notice, they can call the 12315 hotline to complain or report.

　　Perfecting the basic socialist economic system is the institutional guarantee for high-quality economic development and the construction of a modern and powerful country. Standing at a new historical starting point, we should adhere to and improve the socialist basic economic system and promote high-quality economic development in accordance with the requirements put forward by the Fourth Plenary Session of the 19th CPC Central Committee, closely focus on the goal of high-quality development, firmly grasp the important key point of adhering to and improving the socialist basic economic system, and vigorously promote China’s economy to achieve high-quality development.

　　The socialist basic economic system is a great creation of the party and the people and an institutional guarantee for high-quality development.

　　The Fourth Plenary Session of the 19th CPC Central Committee took "public ownership as the main body, multiple ownership economies developing together, distribution according to work as the main body, multiple modes of distribution coexisting, and socialist market economic system" as Socialism with Chinese characteristics’s basic economic system, which is the latest summary and development of China’s socialist basic economic system, a major institutional innovation for China’s socialist basic economic system, and also an important theoretical innovation, reflecting the combination of theoretical innovation, institutional innovation and practical innovation. These economic systems are interrelated and mutually promoted, forming a socialist basic economic system, which is a great creation of the party and the people and an institutional guarantee for high-quality development.

　　The dominant position of public ownership has maintained the nature of the socialist system and the socialist direction of China’s economic development.Adhering to the common development of various forms of ownership has mobilized the enthusiasm of all parties, released new vitality for economic development, improved the enthusiasm and creativity of market players, and cultivated new kinetic energy for economic development. This system maintains the advantages of public assets in quantity, strengthens the control of public economy in important areas of national economy in quality, and realizes the combination of quality and quantity. By improving relevant laws, regulations and policies, we will promote and guide the healthy development of the non-public sector of the economy, so that the public sector of the economy and the non-public sector of the economy can work together to better serve the economic development in the new era.

　　The ownership structure with public ownership as the main body and multiple ownership economies developing together determines the distribution system with distribution according to work as the main body and multiple modes of distribution coexisting.The ownership system determines the distribution system, the dominant position of public ownership determines the distribution according to work, and the coexistence of various forms of ownership determines the coexistence of various modes of distribution. Taking this distribution system as the content of the basic socialist economic system ensures the long-term stability of this distribution system. The basic economic system with distribution according to work as the main body and multiple modes of distribution coexisting plays a positive role in narrowing the income gap, avoiding polarization and improving the income of workers. This distribution system has improved the mechanism that labor, capital, land, knowledge, technology, management, data and other production factors determine their remuneration according to their contributions, and improved the redistribution adjustment mechanism with taxation, social security and transfer payment as the main means, which can rationally adjust the distribution relationship between urban and rural areas, regions and groups, protect legitimate income and ban illegal income.

　　Raising the socialist market economic system to a basic economic system is an affirmation of the combination of socialist system and market economy.The socialist market economy is the combination of socialist system and market economy. Perfecting the socialist market economy system is to build an economic system with "effective market mechanism, dynamic micro-subjects and moderate macro-control", which is a combination of strong market, strong government and strong enterprises. The Fourth Plenary Session of the 19th CPC Central Committee brought the socialist market economy system into the basic economic system, which deepened our party’s understanding of the role of market economy and the relationship between market and government, and showed the world that the direction of developing socialist market economy in China will remain unchanged in the future.

　　On the basis of adhering to the main role of public ownership economy, actively explore various forms of public ownership to promote high-quality economic development.

　　The Decision of the Fourth Plenary Session of the 19th CPC Central Committee put forward "exploring various forms of public ownership" in the paragraph of state-owned economic reform. Putting "exploring various forms of public ownership" in the first sentence has profound significance.

　　On the basis of adhering to the dominant position of public ownership, we can explore the diversification of public ownership.Public ownership and its realization form are the relationship between content and form. Under the premise of adhering to the dominant position of public ownership, the realization form of public ownership can be diversified, and the organizational form and management mode of public assets can be diversified with the goal of maintaining and increasing the value of public assets. The choice of the realization form of public ownership mainly depends on the development level of productive forces. At present, China is still in the primary stage of socialism, and the multi-level and unbalanced development of productive forces in the primary stage of socialism determines the diversification of the realization form of public ownership. The diversification of the forms of public ownership includes two meanings: the first meaning is that the forms of public ownership are diversified, and its own diversification includes ownership by the whole people and collective ownership, etc., and the diversified forms of public ownership can be combined with each other to form more diversified forms of public ownership. At the same time, the carrier of property rights of public ownership is also diversified, and the management system and mode of public ownership can also be diversified. The second meaning is that public ownership coexists with other forms of ownership in the primary stage of socialism, forming an ownership structure with public ownership as the main body and multiple ownership systems coexisting. According to the diversification of public ownership forms, we can promote the separation of ownership and management rights and realize the separation of state-owned economy and state-owned assets in concept and operation, which further shows that the realization form of public ownership economy is not only the type of state-owned enterprises, but also can explore various forms of realization.

　　The state-owned economy should adjust its strategic layout, with progress and retreat.General Secretary of the Supreme Leader has made many speeches on the structural adjustment of the layout of the state-owned economy. He proposed, "Speed up the layout optimization, structural adjustment and strategic reorganization of the state-owned economy. Advance and retreat, do something different, innovate and develop a batch, reorganize and integrate a batch, clean up and withdraw a batch, promote the concentration of state-owned capital in strategic key areas and advantageous industries, and accelerate the strategic adjustment of the state-owned economy. " According to the exposition of the Supreme Leader General Secretary and the spirit of the Fourth Plenary Session of the 19th CPC Central Committee, we need to deepen the supply-side structural reform, adjust and optimize the layout structure of the state-owned economy, revitalize the manufacturing industry and the real economy, actively promote the transformation and upgrading of traditional industries, and accelerate the development of strategic emerging industries. In the economic development of the new era, around the major strategy of serving the country, we should persist in making progress and retreating, and do something different. We should invest more state-owned capital in important industries and key areas that are related to the lifeline of the national economy, especially strategic emerging industries, promote the upgrading of economic structure, optimize the layout of state-owned assets and state-owned enterprises, and cultivate new economic growth points.

　　Take mixed ownership as a new realization form of public ownership.The Fourth Plenary Session of the 19th CPC Central Committee included the reform of mixed ownership in the scope of state-owned economy, which is to bring the reform of mixed ownership into the scope of ownership reform and explore the realization form of public ownership through the reform of mixed ownership. This means that the mixed ownership economy with cross-shareholding and mutual integration of state-owned capital, collective capital and non-public capital is an important realization form of the basic economic system. This form is conducive to amplifying the function of state-owned capital, improving the competitiveness of state-owned capital, expanding the development space of private capital, and promoting and developing all kinds of ownership capital together. As a new form of public ownership, the reform of mixed ownership is not only a breakthrough in the reform of state-owned enterprises, but also brings new opportunities for the development of private enterprises. Through the promotion of mixed ownership reform, we can promote the integrated development of state-owned capital and non-public capital, thus stimulating the endogenous power of China’s high-quality economic development.

　　Improve the policy system to support the new form of public ownership.Exploring the new realization form of public ownership economy is to better adhere to the dominant position of public ownership, and developing mixed ownership economy is a new exploration of the realization form of public ownership and an important way to consolidate China’s basic economic system. However, the development of mixed ownership economy needs to improve the policy system supporting the new realization form of public ownership, and focus on solving the reform motive force of mixed ownership, the equal protection of all kinds of property rights in the reform of mixed ownership and the operation mechanism of mixed ownership. Focusing on the development of mixed ownership, it is necessary to highlight the transformation of operating mechanism, explore a management and control model that adapts to the development of mixed ownership economy, and enhance the enthusiasm and initiative of social capital to participate in the reform of mixed ownership of state-owned enterprises. We will create an integrated development of various ownership entities, use resource elements equally according to law, and form a market environment that is open, fair and just to participate in competition and equally protected by law.

　　Combine the improvement of the high-level socialist market economic system with the construction of a high-level open economic new system to promote high-quality economic development.

　　Achieving high-quality economic development requires certain conditions. This condition is the combination of the role of the government and the role of the market. The combination of a high-level domestic socialist market economic system and a high-level opening-up system is the institutional and institutional basis for achieving high-quality development. To this end, we should combine the improvement of the high-level socialist market economic system with the construction of a high-level open economic new system to promote high-quality economic development.

　　On the basis of giving play to the decisive role of the market in resource allocation, we should correctly handle the relationship between the government and the market, give full play to the role of the government, and combine the role of the government with the role of the market to promote high-quality economic development.With the goal of high-quality development, we should correctly handle the relationship between the government and the market, realize the combination of the government and the market on the basis of effectively exerting the decisive role of the market, and accelerate the high-quality development. On the one hand, realize the combination of government function and market function. In the process of economic development, we should follow the laws of market economy and improve the market system. Clarify the decisive role of the market in resource allocation and truly change the mode of economic development. At the same time, we should change government functions, give play to the role of supervision, guidance and regulation, and play the role of government through macroeconomic regulation, making up for market failures and the supply of public goods. On the other hand, a modern economic system is established through the combination of government and market. Build an economic system with effective market mechanism, dynamic micro-subjects and moderate macro-control. Through the combination of the role of government and market, on the basis of quality reform, efficiency reform, power reform and improving total factor productivity, we will accelerate the construction of a modern economic system with supply-side structural reform as the main line. Build a modern industrial system with coordinated development of real economy, scientific and technological innovation, modern finance and human resources.

　　Realize the combination of a high-level socialist market economy and a higher-level open economic new system to promote high-quality development.On the one hand, China should build a high-level socialist market economic system. Build a high-standard market system, speed up the improvement of the property rights system, and realize effective incentives for property rights. Accelerate the market-oriented allocation of factors and realize the free flow of factors. Create a unified, open and competitive market environment. Improve the property rights definition system, property rights allocation system and property rights transaction system, and promote the market-oriented allocation of factors. In accordance with the spirit of the Fourth Plenary Session of the 19th CPC Central Committee, improve the system and mechanism of scientific and technological innovation, improve the system and mechanism of encouraging and supporting basic research and original innovation, and improve the incentive mechanism of scientific and technological talents and the policy system of scientific and technological management. Establish a technological innovation system with enterprises as the main body, market orientation and deep integration of Industry-University-Research. On the other hand, it is necessary to build a new open economic system at a higher level. The Third Plenary Session of the 18th CPC Central Committee proposed to build a new open economic system, and the Fourth Plenary Session of the 19th CPC Central Committee proposed to build a new open economic system with a higher level. Comparatively speaking, the requirements for opening up are higher and the level is higher, which means that in the new era, we should implement comprehensive opening-up in a wider scope, in a wider field and at a deeper level. In order to achieve this goal, we should strive to create a market-oriented, rule-based and international business environment, further promote the construction of a new open economic system, and promote high-quality economic development with a high level of openness.

　　Author: Ren Baoping, Dean and Professor of Graduate School of Northwest University and Changjiang Scholar of Ministry of Education.

On July 7, the Ministry of Commerce and other 17 departments issued the "Notice on Several Measures for Invigorating Automobile Circulation and Expanding Automobile Consumption", which pointed out that we should support the consumption of new energy vehicles and study the extension of the vehicle purchase tax exemption policy for new energy vehicles after its expiration. Carry out in-depth activities of new energy vehicles to the countryside, encourage qualified places to introduce support policies to the countryside, guide enterprises to increase preferential activities, and promote the consumption and use of new energy vehicles in rural areas.

The following is the full text of the notice:

People’s governments of all provinces, autonomous regions and municipalities directly under the Central Government, Xinjiang Production and Construction Corps:

The automobile industry is a strategic and pillar industry of the national economy. In order to further invigorate automobile circulation, expand automobile consumption, help stabilize the basic economy and ensure the improvement of people’s livelihood, with the consent of the State Council, relevant matters are hereby notified as follows:

First, support the purchase and use of new energy vehicles

(a) to promote cross-regional free circulation, to break the local protection of the new energy vehicle market, each region shall not set the local new energy vehicle models for the record directory, and shall not set unreasonable vehicle parameter indicators for the sales and consumption subsidies of new energy vehicle products.

(2) Support the consumption of new energy vehicles, and study the extension after the expiration of the vehicle purchase tax exemption policy for new energy vehicles. Carry out in-depth activities of new energy vehicles to the countryside, encourage qualified places to introduce support policies to the countryside, guide enterprises to increase preferential activities, and promote the consumption and use of new energy vehicles in rural areas.

(3) Actively support the construction of charging facilities, accelerate the construction of charging facilities such as residential communities, parking lots, gas stations, expressway service areas, passenger and freight hubs, and guide charging pile operators to appropriately reduce charging service fees.

Second, accelerate the active second-hand car market

(four) to cancel the unreasonable restrictions on the development of second-hand car distribution, and make it clear that enterprises with registered residence and business premises outside the second-hand car trading market can carry out second-hand car sales business. For enterprises engaged in new car sales and used car sales, the business scope shall be uniformly registered as "automobile sales" and put on record according to relevant regulations. The filing enterprise shall truthfully fill in the business content and other information, and the commercial department shall promptly push the information of the filing enterprise to the public security organ and the tax department. Since October 1, 2022, if a registered automobile sales enterprise purchases a used car from a natural person, it is allowed to issue a unified invoice for the sale of used cars in reverse and handle the transfer registration procedures accordingly.

(five) to promote the commercialization of second-hand cars, and to clarify that automobile sales enterprises should conduct accounting for second-hand cars purchased and used for sales according to the unified accounting system of the state. Since October 1, 2022, when a registered automobile sales enterprise applies for the transfer registration of a small non-operating used car, the public security organ will implement the management of separate endorsement and issue a temporary license plate. For cities where automobile purchases are restricted, it is clear that used cars purchased by automobile sales enterprises and used for sales do not occupy the number plate index.

(VI) Support the large-scale development of second-hand car circulation, strictly implement the policy of completely canceling the restrictions on the movement of second-hand cars in all regions, and cancel the restrictions on the movement of small non-operating second-hand cars that meet the national emission standards from August 1, 2022, so as to promote the free circulation of second-hand cars and the cross-regional operation of enterprises. Since January 1, 2023, if a natural person sells three or more used cars that have been held for less than one year in a natural year, automobile sales enterprises, used car trading markets, auction enterprises, etc. shall not issue a unified invoice for the sale of used cars, and shall not go through the transaction registration procedures, and the relevant departments shall handle it according to the regulations. Public security organs and tax authorities share verification information, and tax authorities make full use of the shared information to provide information support for relevant enterprises to issue invoices.

Third, promote automobile renewal consumption

(seven) to encourage the comprehensive use of economic and technological means to promote the withdrawal of old vehicles, conditional areas can carry out the old car, accelerate the elimination of old vehicles.

(eight) improve the recycling system of scrapped motor vehicles, and support qualified enterprises to obtain the qualification for recycling scrapped motor vehicles. Enterprises that have obtained qualifications before the implementation of the Detailed Rules for the Management of Scrap Motor Vehicle Recycling, such as those unable to re-complete the qualification confirmation on schedule due to the impact of the COVID-19 epidemic, may be postponed until March 1, 2023. Increase the support for the construction projects of scrapped motor vehicle recycling enterprises. In principle, the nature of the land for enterprise construction projects should be industrial land. For enterprises that have obtained the qualification of scrapped motor vehicle recycling and projects under construction that have obtained the approval of land use or the planning permission of construction projects within 3 months after the issuance of this document, the land should be used according to the determined purposes.

Fourth, promote the sustained and healthy development of parallel automobile imports

(9) Support the parallel import business of automobiles in the import port area of complete automobiles, and the parallel import business of automobiles can be carried out at the import port of complete automobiles after the work plan of parallel import of automobiles is approved by the provincial people’s government and reported to the Ministry of Commerce for the record. We will improve the compulsory product certification and information disclosure system for parallel imported cars, allow enterprises to make a commitment that the imported cars will continue to meet the national six emission standards, and continue to implement the relevant policy requirements for the OBD test and data information of parallel imported cars in the environmental protection information disclosure link.

Fifth, optimize the automobile use environment

(ten) to promote the construction of urban parking facilities, effectively improve the effective supply level of urban parking facilities, accelerate the application of new technologies and new models, and promote the sharing of parking resources and the matching of supply and demand. The newly-built residential area will build parking facilities in strict accordance with the urban parking planning and the construction standards of complete residential communities. Actively expand new parking facilities in combination with urban renewal actions such as the transformation of old urban communities. Make rational use of civil air defense projects, underground spaces of parks and green spaces, and tap the potential to build more parking facilities. All localities should improve the parking fee policy, strengthen the policy support of capital land use, and increase the use of local debt to support the construction of qualified parking facilities.

(11) Develop automobile cultural tourism and other consumption, support the construction and operation of automobile sports events, automobile self-driving sports camps and other projects in terms of land use, study and formulate the conditions for the identification of traditional classic vehicles, and promote the development of traditional classic car-related industries and automobile culture such as exhibition, collection, trading and competitions.

VI. Enriching automobile financial services

(12) Encourage financial institutions to reasonably determine the down payment ratio, loan interest rate and repayment period under the premise of compliance with laws and controllable risks, and increase credit support for automobile consumption. We will develop auto financing leasing in an orderly manner, encourage auto manufacturers, sales enterprises and financing leasing enterprises to strengthen cooperation and increase the supply of financial services.

All regions and relevant departments should earnestly strengthen organization and leadership, refine work measures according to their responsibilities, promote relevant policies and measures to take effect as soon as possible, and further promote the recovery of automobile consumption and the release of potential.

　　() It is planned to spend 6.65 billion yuan to acquire the control right of Huitai Medical, and join forces to cultivate the country’s heavy weapon in the cardiovascular field.

　　On the evening of January 28th, Mindray Medical, a leading domestic medical device company, announced that it planned to acquire the control right of Huitai Medical, a listed medical device company in science and technology innovation board, by means of "agreement transfer+voting right" with its own funds of 6.65 billion yuan, so as to quickly lay out the subdivision track in cardiovascular field.

　　According to the acquisition plan, relevant entities such as the actual controller of Huitai Medical intend to transfer 14.12 million shares of Huitai Medical to Shenmai Control, a subsidiary of Mindray Medical, through agreement transfer, accounting for 21.12% of the company’s total share capital. At the same time, Cheng Zhenghui, the controlling shareholder and actual controller of Huitai Medical, will also give up the voting rights of the 10% shares still held.

　　At the same time as the transfer of this agreement, Shenzhen Maikong intends to acquire all 0.12% general partnership interests of Zhuhai Tongsheng held by Chenyi Hongqi (Mindray Medical holds 99.88% limited partnership interests of Zhuhai Tongsheng), and Zhuhai Tongsheng currently holds 3.49% shares of Huitai. In the end, if all the acquisition plans are successfully implemented, Mindray Medical will hold a total of 24.61% shares of Huitai Medical through its subsidiary Shenmai Control and its concerted action, Zhuhai Tongsheng, and become the largest shareholder of Huitai Medical.

　　6.65 billion yuan acquisition broke into the cardiovascular super track

　　For a long time, the field of medical devices has shown the industry characteristics of being strong and persistent. In addition, there are many subdivided tracks and the technology and channel synergy between tracks is limited. After the development of enterprises in the industry enters a certain stage, they all need to rely on extension mergers and acquisitions to cultivate new growth points and continue to expand their business boundaries, which is also true for Mindray Medical, the industry leader.

　　According to the data of comprehensive industry research report, the global market scale of cardiovascular field has reached 56 billion US dollars, and the market scale of China has also exceeded 50 billion RMB, ranking second in the global and domestic medical device market scale, second only to the field of in vitro diagnosis. In the context of the aging population, the market growth rate in cardiovascular field is significantly higher than that in other fields.

　　Mindray Medical hopes to quickly cut into the cardiovascular track under the tide of aging population by acquiring the controlling stake of Huitai Medical.

　　According to public information, as the acquired object, Huitai Medical has been focusing on the cardiovascular track for many years. In the domestic cardiovascular market monopolized by foreign brands, it has achieved a stable position in the segmentation fields such as cardiac electrophysiology, coronary artery access and peripheral vascular intervention, and mastered the full-line R&D and production capacity from upstream raw materials to products. It is a leading enterprise in the domestic cardiovascular field.

　　Among them, in the field of electrophysiology, the electrophysiology electrode catheter and controllable radiofrequency ablation catheter under Huitai Medical, as well as the floating temporary pacing electrode catheter approved for listing in 2020, are the first domestic products to obtain relevant registration certificates, and are recognized as national key new products by the Ministry of Science and Technology. In the field of vascular intervention, Huitai Medical has been involved in coronary artery access and peripheral vascular intervention, and a number of research and development products have filled the domestic clinical gaps.

　　Breakthrough innovative products have also brought rapid performance growth to Huitai Medical. In 2023, the company expects to achieve a net profit of 510-565 million yuan, a year-on-year increase of 42%-58%. The company’s value has also been recognized by market investors, and its share price has been stable above 300 yuan/share for a long time, ranking first in science and technology innovation board.

　　In order to get the leading position in this cardiovascular field, Mindray Medical has also made real money. It is understood that the comprehensive cost of this acquisition is about 450 yuan per share, which is about 25% higher than the latest closing price of Huitai Medical.

　　In this regard, Mindray Medical explained in the announcement that the starting point and timing of the acquisition of control rights are based on the company’s future strategic development direction and rhythm, aiming to help Mindray Medical quickly cut into the cardiovascular track by acquiring outstanding domestic companies and make positive contributions to Mindray’s long-term rapid growth.

　　Buying control rights at a premium is also a common operation in the capital market. Referring to the cases of transfer of control rights in Shanghai and Shenzhen Stock Exchanges since 2021, the average premium rate reached 29.58%, among which the average premium rate of medical-related cases reached 32.84%. In addition, in recent years, the average premium rate reached 34.43% in the cases of the transfer of control rights in the field of non-pharmaceutical medical care and health in overseas markets with a transaction scale of more than 500 million US dollars. In addition, from the perspective of Mindray Medical’s cash flow, as of the end of September 2023, the balance of the company’s monetary funds was 19.667 billion yuan, and the transaction amount was less than 1/3 of the book funds, which did not pose great pressure.

　　Extension acquisition gives birth to a new domestic leader.

　　In recent years, Mindray Medical has paid special attention to the driving effect of extended mergers and acquisitions on the company’s development. In 2021, the company acquired HyTest Bio, a world-renowned company in the field of IVD raw materials, and realized the independent control of core technologies in the field of IVD raw materials. In 2023, Mindray Medical once again completed the acquisition of DiaSys Holdings in Germany, and successfully built a global supply chain platform for in vitro diagnostic products, laying the foundation for the full internationalization of IVD business.

　　From the above acquisition cases, it can be found that Mindray Medical always hopes to go deep into the field and intensively cultivate new works with the role of industrial investment integrator, which will bring product R&D innovation and direct improvement of production and sales capabilities for both parties. The acquisition of Huitai Medical will also bring considerable market imagination to the two companies.

　　In the future, based on the rich experience of Mindray Medical and Huitai Medical in the field of medical equipment and consumables, a brand-new pattern of "Mindray Medical Equipment+Huitai Medical Consumables" is coming out. Mindray’s strong product engineering and system integration capabilities are also expected to further improve the performance of Huitai medical products. Based on Mindray Medical’s in-depth overseas market sales service system and different levels of customer resources, Huitai Medical’s cutting-edge innovative products can also be sold to a broader international market.

　　It can be said that the combined competitive advantage and cost-effective advantage brought by the combination of strong and powerful forces are becoming the direct weapon for the products of the two companies to break through the global market. The industrial integration with complementary resources is also expected to give birth to a new leader in the industry and open a new export market for domestic medical devices from the cardiovascular track.

　　(): In 2023, the cumulative sales volume of tap water was 236 million cubic meters, a year-on-year decrease of 2.71%.

　　Jiangnan Water Affairs announced the operating data. In 2023, the company accumulated 262 million cubic meters of tap water supply, a year-on-year decrease of 2.22%. The cumulative sales volume of tap water was 236 million cubic meters, a year-on-year decrease of 2.71%.

　　The controlling shareholder and actual controller of Youfa Group released the pledge of 121 million shares.

　　Youfa Group announced that on January 26 and 29, 2024, the company received notices from controlling shareholders and actual controllers Li Maojin, Chen Kechun and Liu Zhendong, and pledged its 121 million shares in Xinyin Wealth Management Co., Ltd. to be released. On January 26 and 29, 2024, both parties completed the procedures for releasing the above-mentioned restricted shares in China Securities Depository and Clearing Co., Ltd.

　　Huaibei Mining Industry: In 2023, the sales volume of commercial coal decreased by 5.27% year on year.

　　() Announcement, in 2023, the output of commercial coal was 21,973,400 tons, down 4.06% year-on-year; The sales volume of commercial coal was 17.832 million tons, down 5.27% year-on-year.

　　New Huangpu: Declare and issue public offering REITs for affordable rental housing.

　　() Announcement, the company intends to carry out the application and issuance of public offering of affordable rental housing-real estate investment trust fund in infrastructure field.

　　Weichuang Electric: It is planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone.

　　Weichuang Electric announced that the company signed the Investment Cooperation Agreement with the Changzhou Zhonglou Economic Development Zone Management Committee, and plans to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province, with a total planned investment of 500 million yuan.

　　New Huangpu: It is planned to declare and issue public offering REITs for affordable rental housing.

　　On the evening of January 29th, New Huangpu announced that in order to actively respond to the national housing policy of renting and selling at the same time, effectively revitalize the existing assets, form a virtuous circle of existing assets and new investment, and create important opportunities for promoting the rolling development of main business investment, the company plans to publicly raise the real estate investment trust funds (REITs) in the field of affordable rental housing-infrastructure (hereinafter referred to as "public REITs for affordable rental housing").

　　Weichuang Electric: It is planned to invest 500 million yuan to build a high-end electrical equipment production base project.

　　Weichuang Electric announced on the evening of January 29th that the company and Changzhou Zhonglou Economic Development Zone Management Committee signed the Investment Cooperation Agreement, and planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province. The total investment of the project is 500 million yuan, which is used to introduce high-voltage motors, transformers, water coolers, vibration platforms, incubators and other equipment, mainly engaged in high-voltage frequency converters, multi-transmission frequency converters and other businesses.

　　New Huangpu plans to declare and issue public offering REITs for affordable rental housing.

　　The new Huangpu announced that the company held the fourth meeting of the ninth board of directors on January 27, 2024, and reviewed and approved the Proposal on the Application and Issuance of Public Offering REITs for Affordable Rental Housing.

　　It is reported that the company intends to select the leased housing project of plot 02-03A-01a, Unit MHPO-0306, Meilong Town, Minhang District (referred to as "Meilong Community Project") as the underlying asset for the first time to declare and issue public offering REITs for affordable rental housing (the final specific project name is subject to the project declaration document). Meilong Community Project started construction in April 2020, obtained the certification of affordable rental housing in June 2021, completed the overall completion acceptance procedures in November 2022, and officially entered the market for supply in February 2023.

　　Warner Pharmaceutical Factory: Received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder (Ⅲ).

　　Warner Pharmaceutical Company announced on the evening of January 29th that it had received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder (III) approved and issued by National Medical Products Administration. Compound Polyethylene Glycol Electrolyte Powder (III) was used for colon cleaning preparation of patients before the following situations: endoscopy or radiological examination; Colon surgery.

　　Weichuang Electric plans to build a high-end electrical equipment production base project in Changzhou with a total investment of 500 million yuan.

　　Weichuang Electric announced that the company signed the Investment Cooperation Agreement with the Changzhou Zhonglou Economic Development Zone Management Committee, and planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province, and set up a subsidiary in Changzhou Zhonglou Economic Development Zone. The total investment of the project is 500 million yuan, which is used to introduce high-voltage motors, transformers, water coolers, vibration platforms, incubators and other equipment, mainly engaged in high-voltage frequency converters, multi-transmission frequency converters and other businesses.

　　Warner Pharmaceutical Factory: Received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder.

　　Warner Pharmaceutical Factory announced that it had received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder approved and issued by National Medical Products Administration, and the compound Polyethylene Glycol Electrolyte Powder was used for colon cleaning preparation of patients before the following situations: endoscopy or radiological examination; Colon surgery.

　　Warner Pharmaceutical Company obtained the registration certificate of compound polyethylene glycol electrolyte powder (Ⅲ).

　　Warner Pharmaceutical Company announced that it had received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder (Ⅲ) approved and issued by National Medical Products Administration.

　　It is reported that compound polyethylene glycol electrolyte powder (ⅲ) is used for colon cleaning preparation of patients before the following situations: endoscopy or radiological examination; Colon surgery. This product is suitable for adults. Polyethylene glycol (4000) is a long-chain polymer, with which water molecules are bound by hydrogen bonds. After taking this medicine orally, the volume of intestinal fluid increased. These unabsorbed intestinal fluids make the medicine have catharsis characteristics.

　　Dayuan Pump Industry plans to transfer two cases of land use rights and related assets for 140 million yuan.

　　() Announced that the company intends to transfer two state-owned land use rights, buildings and other assets located in Danya Industrial Zone, zeguo town, Wenling City, Zhejiang Province to Zhejiang Lumei Pump Technology Co., Ltd. According to the assets appraisal report issued by Taizhou Xingyuan Assets Appraisal Co., Ltd. (Taixingping (2024) No.26) and through negotiation between both parties, the transaction price is determined to be RMB 140 million (including tax).

　　It is reported that according to the agreement, the relevant assets will be delivered in 2024. According to preliminary calculations, after the completion of this transaction, it is expected to increase the profit before corporate income tax in the current year by about RMB 50 million.

　　Dayuan Pump Industry: It is planned to sell some assets for 140 million yuan.

　　Dayuan Pump Industry announced on the evening of January 29th that it intends to transfer two state-owned land use rights, houses and buildings above the land to Zhejiang Lumei Pump Technology Co., Ltd. (hereinafter referred to as "Lumei Technology"). Through negotiation between both parties, it is determined that the transaction price is 140 million yuan (including tax), and the related assets will be delivered in 2024. After preliminary calculation, it is estimated that the profit before enterprise income tax will increase by about 50 million yuan in the current year.

　　Hengrui Pharma: The subsidiary product tacrolimus sustained-release capsules was approved by the US FDA.

　　() Announcement: Chengdu Sheng Di Pharmaceutical Co., Ltd., a subsidiary of the company, recently received a notice from the FDA that the company’s application for a simple new drug for tacrolimus sustained-release capsules (ANDA, American generic drug application) has been approved, which is the first generic drug approved by the FDA in the United States and the first generic product in China.

　　() A general meeting of shareholders will be held on February 27th to consider the proposal of electing Ms. Wang Yongting as a non-independent director of the eighth board of directors of the company.

　　Fuling Electric Power announced that the first extraordinary shareholders’ meeting will be held on February 27, 2024, and online voting will be conducted on the same day. Date of record is February 20th, and investors who hold shares of Fuling Power can vote after the market closes on that day.

　　Meeting place: Company meeting room at No.20 Wangzhou Road, Fuling District, Chongqing.

　　A total of 1 proposal was audited at this general meeting of shareholders, as follows:

　　1. Proposal on electing Ms. Wang Yongting as a non-independent director of the eighth board of directors of the company.

　　Hengrui Pharma: Tacrolimus sustained-release capsules were approved by FDA.

　　Hengrui Pharma announced that Chengdu Sheng Di Pharmaceutical Co., Ltd., a subsidiary of the company, received a notice from the US Food and Drug Administration (hereinafter referred to as "FDA") that the company’s application for a simple new drug for tacrolimus sustained-release capsules (ANDA, that is, the application for generic drugs in the United States) has been approved, which is the first generic drug approved by the US FDA and the first generic product in China.

　　In vivo and in vitro experiments have proved that tacrolimus is a powerful immunosuppressant, which can inhibit the production of cytotoxic lymphocytes, the activation of T cells, the proliferation of T helper cell-dependent B cells, the production of lymphatic factor (such as IL-2, IL-3 and IFN-γ) and the expression of IL-2 receptor.

　　The controlling shareholders of Guizhou Sanli and their concerted actions reduced their holdings by 2.9576%.

　　() Announcement was issued. As of the disclosure date of this announcement, the reduction period has expired, and the controlling shareholders and their concerted actions have reduced their holdings by a total of 12,122,300 shares, accounting for 2.9576% of the company’s total share capital.

　　Shanghai Wei, the major shareholder of Sanyou Medical, is reducing its shareholding by 1.35%.

　　Sanyou Medical announced that during the period from January 25th to January 29th, 2024, the shareholder of the company, Shanghai Zhengzheng Enterprise Management Partnership (Limited Partnership) ("Shanghai Zhengzheng"), reduced its shareholding by 3,344,600 shares, accounting for 1.35%, and its shareholding ratio decreased from 7.07% to 5.72%.

　　The approval of Goodwin’s fixed stock has expired.

　　Goodway announced that on February 13th, 2023, the company received the "Reply on Agreeing to the Registration of Goodway Technology Co., Ltd. to Issue Shares to Specific Objects" issued by China Securities Regulatory Commission (No.219, ZJK [2023]), and approved the company’s application for the registration of issuing shares to specific objects, with 12 replies from the date of agreeing to register (January 31st, 2023).

　　It is reported that the company has been actively promoting the issuance of this non-public offering of shares after obtaining the approval. However, due to various reasons such as changes in the capital market environment and the timing of issuance, the company failed to implement this non-public offering of shares within the validity period of the approval, and the approval will automatically expire.

　　Xuefeng Technology: 65.87 million restricted shares will be listed and circulated on February 5.

　　() Announced that the company’s stock listing type is non-public offering of shares. The total number of shares listed and circulated this time is 65.87 million shares, and the date of listing and circulation this time is February 5, 2024.

　　The total provision for impairment of proposed assets of Danhua Technology in 2023 is 98,774,200 yuan.

　　() Announcement, the company intends to make provision for impairment of assets with possible signs of impairment within the scope of consolidated statements as of December 31, 2023, totaling 98,774,200 yuan.

　　Sinopharm Modern: Lidocaine Hydrochloride Injection, a subsidiary, passed the consistency evaluation of generic drugs.

　　() Announcement: Shanghai Hyundai Hasen Pharmaceutical Co., Ltd., a holding subsidiary, received the Notice of Approval for Drug Supplement Application issued by National Medical Products Administration, and approved lidocaine hydrochloride injection to pass the consistency evaluation of generic drug quality and efficacy.

　　Sinopharm Modern: Lidocaine Hydrochloride Injection, a holding subsidiary, passed the conformity evaluation of generic drugs.

　　On January 29, Sinopharm Hyundai announced that the holding subsidiary lidocaine hydrochloride injection passed the consistency evaluation of generic drugs; The holding subsidiary obtained the registration certificate of ambroxol hydrochloride oral solution drug.

　　Lianhuan Pharmaceutical received the results of GMP compliance inspection.

　　() Announcement: The company learned from the website of Jiangsu Provincial Drug Administration that the Notice of GMP Compliance Inspection Results, and conducted good manufacturing practice compliance inspection and evaluation on Jiangsu Lianhuan Pharmaceutical Co., Ltd. according to the relevant provisions of the Drug Administration Law and the Measures for the Supervision and Administration of Drug Production, and the results met the requirements.

　　This is the first time that Fluhydrocortisone Acetate has passed the GMP compliance inspection. The GMP compliance inspection of Troxerutin and Terfenadine Granules is the certification of resumed production varieties after the change of production site, and they are all collinear with other varieties, and no new investment has occurred.

　　Kang Enbei: Repurchase 5,471,800 shares of the company for the first time by centralized bidding transaction.

　　On January 29th, () announced that the company repurchased 5,471,800 A shares of the company through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 0.21% of the company’s total share capital of 2,570 million shares. The highest price of the repurchase transaction was RMB 4.7 yuan/share, and the lowest price was RMB 4.57/share. The total amount of funds paid was RMB 25,265,300 (excluding stamp duty, trading commission and other transactions)

　　According to the previously disclosed Proposal on Repurchase of Company’s Shares by Centralized Bidding, the company intends to use its own funds to repurchase the company’s shares by centralized bidding through the trading system of Shanghai Stock Exchange for the implementation of equity incentives. The total amount of funds to be repurchased is not less than RMB 200 million (inclusive) and not more than RMB 400 million (inclusive); The price of repurchased shares shall not exceed RMB 7 yuan/share (inclusive).

　　(Shanghai Stock Exchange)

　　Juhua Co., Ltd.: The refrigerant revenue in 2023 was 5.807 billion yuan, a year-on-year decrease of 15.05%.

　　() Announced the main operating data from January to December, 2023. The revenue of the company’s main product fluorine chemical raw materials was 1.05 billion yuan, a year-on-year decrease of 20.47%; Refrigerant revenue was 5.807 billion yuan, a year-on-year decrease of 15.05%.

　　Mindray Medical intends to be the main enterprise in the field of electrophysiology, Huitai Medical.

　　Mindray Medical announced on the evening of January 28th that the company intends to acquire 14.12 million ordinary shares of Huitai Medical held by Cheng Zhenghui, Cheng Ling, Dai Zhenhua and other transferors by means of agreement transfer, accounting for 21.12% of the total share capital of the target company, with a total transfer amount of RMB 6.652 billion.

　　The main business of Huitai Medical is the research and development, production and sales of products such as electrophysiology, coronary artery access and peripheral vascular intervention.

　　At the same time, Cheng Zhenghui, the actual controller of Huitai Medical, promised to voluntarily, permanently and irrevocably give up the voting rights of 10% of the shares of the target company from the date when he received all the share transfer price according to the agreement.

　　In addition, Shenmai Control also intends to acquire all 0.12% general partnership interests of Zhuhai Tongsheng Investment Partnership (Limited Partnership) held by Chenyi Hongqi (Beijing) Consulting Co., Ltd. (hereinafter referred to as "Zhuhai Tongsheng"), and Zhuhai Tongsheng currently holds 3.49% shares of Huitai Medical.

　　After the completion of the above three transactions, Shenmaikong will directly hold 14.12 million shares of Huitai Medical, accounting for 21.12% of the total share capital of Huitai Medical; Zhuhai Tongsheng, the concerted action person of Shenzhen Maikong, directly holds 2,335,300 shares of Huitai Medical, accounting for 3.49% of the total share capital of Huitai Medical. Shenzhen Maikong and its concerted action person Zhuhai Tongsheng hold 16,455,600 shares of Huitai Medical, accounting for 24.61% of the total share capital of Huitai Medical. The controlling shareholder of Huitai Medical will be changed to Shenzhen Maikong, and the actual controllers will be changed to Li Xiting and Xu Hang.

　　The proportion of UFIDA network repurchase reached 1.01%, costing 666 million yuan.

　　() Announcement: As of January 29, 2024, the company has repurchased 34,654,400 shares, accounting for 1.0137% of the company’s current total share capital, an increase of 0.1202% compared with the last disclosure. The highest purchase price is 23.39 yuan/share, the lowest purchase price is 12.35 yuan/share, and the total amount paid is 666 million yuan (no

　　Anfu Technology: Shareholders intend to reduce their shares by no more than 1%.

　　() On the evening of January 29th, it was announced that Zhang Jinghong, a shareholder holding 5.77% of the shares, planned to reduce his shareholding by no more than 1%.

　　TBEA: The holding company plans to invest in the construction of Xi ‘an digital factory project.

　　On January 29th, () announced that the holding company TBEA Xi ‘an Electric Technology Co., Ltd. planned to invest in the construction of Xi ‘an digital factory project with a total investment of 1.16 billion yuan.

　　The Asian strategy of Goldman Sachs, the shareholder of Xianheng International, has reduced its holdings by 1.99% and reduced its holdings by more than half.

　　() Announcement was issued. On January 29, 2024, the company received the Letter of Notice on the Progress of Share Reduction issued by Goldman Sachs Asia Strategic Pte. Ltd. (hereinafter referred to as "Goldman Sachs Asia Strategy"). As of January 29, 2024, Goldman Sachs Asia Strategy had reduced its shareholding by 8.195 million shares, accounting for 1.99% of the company’s total share capital, without centralized bidding. The number of this reduction plan has exceeded half, and the implementation of this reduction plan has not yet been completed.

　　Longji Green Energy: It is planned to implement the first increase on January 30, 2024.

　　() Announcement, the company received a notice from the chairman, Mr. Zhong Baoshen, that it intends to implement its first increase on January 30, 2024, and will continue to implement its increase plan in the future.

　　Longji Green Energy: Zhong Baoshen, Chairman of the Board of Directors, plans to implement the first increase on January 30, 2024.

　　Longji Green Energy announced that it was previously disclosed that Chairman Zhong Baoshen plans to increase the company’s shares in a way allowed by the Shanghai Stock Exchange system within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Chairman Zhong Baoshen that it planned to implement its first increase on January 30, 2024, and will continue to implement its increase plan.

　　Langfang development: Evergrande Real Estate’s shares in the company have been waiting for freezing, accounting for 20% of the company’s total share capital.

　　() Announcement: As of the date of this announcement, Evergrande Real Estate holds 76,032,050 shares, accounting for 20% of the company’s total share capital. After the shares were frozen, the cumulative number of shares held by Evergrande Real Estate was 76,032,050, accounting for 100% of the total shares held by Evergrande and 20% of the total share capital of Evergrande.

　　Longji Green Energy: The chairman of the board plans to implement the first increase on January 30, 2024.

　　Longji Green Energy announced on the evening of January 29th that Chairman Zhong Baoshen plans to increase the company’s shares within 12 months from October 31st, 2023 through the way permitted by the Shanghai Stock Exchange system, and the amount of increase is not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to implement its first increase on January 30, 2024, and will continue to implement its increase plan.

　　() A shareholders’ meeting will be held on February 19th to consider the proposal on the settlement of the initial public offering of shares and the permanent replenishment of working capital with the remaining raised funds.

　　Guansheng shares announced that the second extraordinary general meeting of shareholders will be held on February 19, 2024, and online voting will be held on the same day. Date of record falls on February 6th, and investors who hold Guansheng shares after the market closes on that day can vote.

　　Venue: No.1 Gaoxiang Road, Ouhai High-tech Industrial Park, Wenzhou City, Zhejiang Province.

　　A total of 1 proposal was audited at this general meeting of shareholders, as follows:

　　1. Proposal on the Settlement of the Initial Public Offering of Shares and the Permanent Supplement of the Funds Raised from the Savings to the Working Capital.

　　Top Group will hold a shareholders’ meeting on February 19th to consider two proposals.

　　() Announce that the first extraordinary general meeting of shareholders will be held on February 19, 2024, and online voting will be conducted on the same day. Date of record is February 6th, and investors who hold shares of Top Group can vote after the market closes on that day.

　　Venue: Meeting Room C-105, Company Headquarters, No.268 Yuwangshan Road, Beilun District, Ningbo.

　　A total of two proposals were audited at this general meeting of shareholders, as follows:

　　1. Proposal on increasing the amount of entrusted financing for idle raised funds.

　　2. Proposal on adding idle raised funds to supplement the liquidity line.

　　() The net profit for 2023 was reduced by 320 million to 420 million yuan, which plummeted by 69% to 77% year-on-year.

　　Weiwei Gaoxin disclosed the announcement of pre-reduction of annual results in 2023. The company expects the net profit attributable to shareholders of listed companies to be 320 million yuan to 420 million yuan during the reporting period, down 76.63% to 69.33% year-on-year. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 200 million yuan to 300 million yuan, down 85.41% to 78.12% year-on-year.

　　During the reporting period, the competition in the polyvinyl alcohol (PVA) industry intensified, and the market changed greatly. The domestic and foreign trade market prices of the main products, vinyl acetate and polyvinyl alcohol, fell by about 40%, and the market prices of other products also fell to varying degrees, narrowing the profit margin.

　　Consistency evaluation of Sinopharm Hasen drugs, a subsidiary of Sinopharm Modern Holdings, passing generic drugs.

　　Sinopharm Hyundai announced that Shanghai Hyundai Hasen (Shangqiu) Pharmaceutical Co., Ltd. (hereinafter referred to as Sinopharm Hasen), a holding subsidiary of the company, received the Notice of Approval for Drug Supplement Application approved by National Medical Products Administration, and approved lidocaine hydrochloride injection (5ml：0.1g) to pass the consistency evaluation of generic drug quality and efficacy.

　　It is reported that lidocaine hydrochloride injection is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. Can be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and can also be used for digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheter.

　　Langfang development: Evergrande Real Estate’s shares in the company have been waiting for freezing, accounting for 20% of the total share capital.

　　Langfang Development Announcement: As of the date of this announcement, Evergrande Real Estate holds 76,032,050 shares, accounting for 20% of the company’s total share capital. After the shares were frozen, the cumulative number of shares held by Evergrande Real Estate was 76,032,050, accounting for 100% of the total shares held by Evergrande and 20% of the total share capital of Evergrande.

　　On January 29th, 2024, the company received the Notice of Judicial Freeze and Judicial Transfer of Equity from China Securities Depository and Clearing Co., Ltd. Shanghai Branch (No.0129-1 in 2024) and the Notice of Assistance in Execution from Lianyungang Intermediate People’s Court [(2023) Su 07 Zhi No.285]. Due to the dispute over the loan contract between Lianyungang Cangwu Sub-branch of Agricultural Bank of China Co., Ltd. and Evergrande Real Estate Group Co., Ltd., the ruling of (2023) Su 07 Zhi No.285 made by Lianyungang Intermediate People’s Court of Jiangsu Province has taken legal effect, and 76,032,050 shares of the company held by Evergrande Real Estate are waiting to be frozen.

　　Dayuan Pump Industry: It is planned to sell some assets for 140 million yuan.

　　On the evening of January 29th, Dayuan Pump Industry announced that it planned to sell two state-owned land use rights, houses and buildings above the land in Danya Industrial Zone, zeguo town, Wenling City, Zhejiang Province to Zhejiang Lvmei Pump Technology Co., Ltd., with a total transaction price of 140 million yuan (including tax). Both parties to the transaction refer to the evaluation results and determine the transaction price through consultation. After the transaction is completed, it is estimated that the profit before enterprise income tax in the current year will be increased by about 50 million yuan, which will have a positive impact on the company’s profit in the relevant reporting period.

　　Weichuang Electric: Signed Investment Cooperation Agreement with Changzhou Zhonglou Economic Development Zone Management Committee.

　　On the evening of January 29th, Weichuang Electric announced that the company had signed the Investment Cooperation Agreement with the Changzhou Zhonglou Economic Development Zone Management Committee, and planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province. The total planned investment of the project is 500 million yuan (subject to the actual investment in the end).

　　Haili Bio: Jiemen Bio, a wholly-owned subsidiary, obtained the invention patent certificate.

　　On the evening of January 29th, () announced that Shanghai Jiemen Biotechnology Co., Ltd. (hereinafter referred to as "Jiemen Biotechnology"), a wholly-owned subsidiary of the company, had recently received the invention patent certificate issued by China National Intellectual Property Administration, with the invention name: a serum-free medium suitable for the adherent growth of hybridoma cells. The acquisition of the above invention patents is the embodiment and extension of the important core technology of Jiemen Bio.

　　Antu Bio: It is planned to buy back shares at a price of 250-500 million yuan.

　　On January 29th, () announced that it planned to buy back shares at a price of 250-500 million yuan, cancel all of them and reduce the registered capital of the company. The repurchase price shall not exceed 60 yuan/share.

　　Longji Green Energy: Chairman Zhong Baoshen plans to increase his holdings for the first time on January 30th.

　　Longji Green Energy announced that the company received a notice from Chairman Zhong Baoshen that it plans to implement its first increase on January 30, 2024, and will continue to implement its increase plan. Longji Green Energy has previously disclosed that Chairman Zhong Baoshen plans to increase the company’s shares within 12 months from October 31, 2023, with an increase of not less than 100 million yuan.

　　Dayuan Pump Industry: The assets to be sold will increase the profit before enterprise income tax by about 50 million yuan.

　　Dayuan Pump Industry announced that the company intends to transfer two state-owned land use rights, buildings and other assets located in Danya Industrial Zone, zeguo town, Wenling City, Zhejiang Province to Zhejiang Lumei Pump Industry Technology Co., Ltd. The transaction price is 140 million yuan (including tax). According to preliminary calculation, after the completion of this transaction, it is expected that the profit before enterprise income tax will increase by about 50 million yuan in the current year.

　　Baosteel packaging: It is planned to buy back shares at a price of RMB 50 million to RMB 100 million.

　　() On the evening of January 29th, it was announced that it was planned to buy back shares at a price of 50 million yuan to 100 million yuan, and the upper limit of the repurchase price was planned to be no more than 7.66 yuan/share. This share repurchase is intended to be used for the continuous implementation of the equity incentive plan in the future.

　　Antu Bio: It is planned to buy back shares at a price of 250 million yuan-500 million yuan.

　　Antu Bio announced on the evening of January 29th that it plans to buy back its shares at a price of 250-500 million yuan, with the repurchase price not exceeding 60 yuan/share. All the repurchased shares will be cancelled and the registered capital of the company will be reduced.

　　Tang Yu Investment, shareholder of Alice, completed the reduction of 2.34% shares.

　　Alice announced that Jiaxing Tangyu Investment Partnership (Limited Partnership) (hereinafter referred to as "Tangyu Investment"), a shareholder of the company, has reduced its shareholding by 10,514,700 shares through centralized bidding and block trading, accounting for 2.34% of the company’s total share capital. The planned time interval for this reduction has expired.

　　Baosteel packaging: It is planned to buy back shares from 50 million yuan to 100 million yuan.

　　Baosteel packaging announced that it plans to buy back shares at a price of 50 million yuan to 100 million yuan for the continuous implementation of the equity incentive plan in the future, with the repurchase price not exceeding 7.66 yuan per share.

　　Yifeng Pharmacy: Vice President Tian Wei resigned for personal reasons.

　　On January 29th, () announced that the board of directors of the company recently received a written resignation report submitted by Tian Wei, vice president of the company, and Tian Wei applied to resign as vice president of the company for personal reasons. According to relevant regulations, Tian Wei’s application for resignation will take effect from the date when it is delivered to the board of directors of the company. After Tian Wei resigned as vice president, he will no longer hold other positions in the company.

　　(Shanghai Stock Exchange)

　　42,455,800 restricted shares of Secco Sid will be listed and circulated on February 6th.

　　Secco Sid announced that the company’s total number of shares listed and circulated this time was 42,455,800 shares, and the listing date was February 6, 2024.

　　By the end of the fourth quarter, the contracted construction area of Zhujiang shares was 38.1402 million square meters.

　　() Announced that by the end of the fourth quarter of 2023, the company (including Guangzhou Pearl River Urban Management Service Group Co., Ltd. and Guangzhou Pearl River Sports and Culture Development Co., Ltd.) was in charge of 371 residential, public and stadium projects, with a total contracted construction area of about 38.1402 million square meters. Among them, there are 148 residential projects with a construction area of about 19,368,500 square meters; 198 public construction projects with a construction area of about 15,688,800 square meters; There are 25 sports venues with a construction area of about 3,082,800 square meters, including 20 large-scale sports venues with a construction area of about 2,625,100 square meters.

　　The controlling shareholder of Xiamen Xiangyu completed the increase of 1.01% of its shares.

　　() Announcement: From October 31, 2023 to January 29, 2024, Xiamen Xiangyu Group Co., Ltd. (referred to as "Xiangyu Group"), the controlling shareholder of the company, increased its holdings of 22,901,100 shares by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for 1.01% of the company’s issued shares, with a cumulative increase of 150 million yuan. This increase plan was completed.

　　Antu Bio will hold a shareholders’ meeting on February 20th to consider the proposal of repurchasing the company’s shares by centralized bidding.

　　Antu Bio announced that the first extraordinary general meeting of shareholders will be held on February 20, 2024, and online voting will be held on the same day. Date of record is February 2nd, and investors who hold Antu Bio shares can vote after the market closes on that day.

　　Meeting place: company meeting room.

　　A total of 1 proposal was audited at this general meeting of shareholders, as follows:

　　1. Proposal on the plan of repurchasing the company’s shares by centralized bidding transaction.

　　() A general meeting of shareholders will be held on February 20th to review the proposal on the company’s 2024 annual guarantee amount.

　　Yijing Optoelectronics announced that the first extraordinary general meeting of shareholders will be held on February 20, 2024, and online voting will be held on the same day. Date of record is February 6th, and investors who hold Yijing Optoelectronic shares after the market closes on that day can vote.

　　Meeting place: meeting room on the 8th floor of Changzhou Yijing Optoelectronic Technology Co., Ltd. (No.18 Jinwu Road, Jintan District, Changzhou City, Jiangsu Province).

　　A total of 1 proposal was audited at this general meeting of shareholders, as follows:

　　1. Proposal on Estimated Guarantee Amount of the Company in 2024.

　　(): Sign a long-term loan agreement with IFC, the international finance company, with the maximum amount not exceeding USD 100 million equivalent to RMB.

　　On January 29th, Health Yuan announced that the company signed the Loan Agreement between Health Yuan Pharmaceutical Group Co., Ltd. and International Finance Corporation with International Finance Corporation (IFC) on the same day, and the company intends to apply to IFC for a long-term loan with the maximum principal amount not exceeding USD 100 million equivalent and the final repayment date not later than May 15th, 2032. The loan interest rate is no more than 1.0% on the basis of the RMB Fixed Base Rate determined at the time of lending. The loan is mainly used for the company to build production and R&D facilities in Henan and Guangdong, and other investments related to key treatment fields, including working capital requirements.

　　The announcement shows that the company’s application for long-term loans from IFC can effectively meet the company’s future business development needs, effectively expand the company’s diversified financing channels, reduce financing costs, and provide good financing support for the company’s sustained, stable and healthy development.

　　(Shanghai Stock Exchange)

　　Baiaotai: It is estimated that the net loss in 2023 will be 350-450 million yuan, a year-on-year decrease, and the sales in adalimumab will increase year-on-year.

　　On January 29th, Baiaotai announced that the company expected a net loss of 350-450 million yuan in 2023, compared with a net loss of 480 million yuan in the same period last year, a year-on-year decrease.

　　In 2023, the company’s operating income is expected to increase by 200 million yuan to 300 million yuan compared with the same period of last year. The main reason is that the company actively expands the market, and the sales of Geluoli (adalimumab) injection has steadily increased compared with the same period of last year; Second, the company’s drug Shireili (Tozumab) injection received the Drug Registration Certificate issued by National Medical Products Administration in January 2023, and the drug sales revenue increased; Third, with the increase in the sales of Bevacizumab injection, the revenue from drug sales commission and sales milestone increased.

　　During the reporting period, the R&D expenditure is expected to increase by 100 million yuan to 200 million yuan compared with the same period of last year. On the one hand, the company adheres to the innovation-driven development strategy, attaches great importance to drug research and development, and continuously enriches the R&D pipeline, and the R&D investment increases during the reporting period; On the other hand, many projects of the company are in clinical phase III, and the clinical trial fees and technical service fees increase, resulting in an increase in research and development expenses.

　　(Shanghai Stock Exchange)

　　In the fourth quarter, Space-Time Technology signed a new contract worth 163 million yuan.

　　() Announcement: From October to December in 2023, the company signed 12 new projects, with a new contract amount of 163 million yuan.

　　Zhang Jinghong, a shareholder of Anfu Technology, intends to reduce his shareholding by no more than 1%.

　　Anfu Technology announced that according to the market price, Zhang Jinghong, a shareholder of the company, intends to reduce the number of shares of the company by no more than 1.456 million shares (that is, no more than 1% of the total number of shares of the company) within 90 days after 15 trading days from the date of disclosure of this announcement.

　　(): It is estimated that in 2023, the company will make provision for depreciation of cobalt-related inventories of about 43 million yuan.

　　Pengxin Resources announced that it is estimated that in 2023, the company will make provision for depreciation of cobalt-related inventories of about 43 million yuan. At the same time, the company’s Congo (DRC) cathode copper production line was overhauled and debugged, and local power cuts and other factors affected the production and sales of cathode copper. In addition, West Gold Plant (Pty) Ltd., which was newly incorporated into the scope of merger, lost about 31 million yuan. The above forecast data are only preliminary accounting data, and the specific and accurate financial data are subject to the audited 2023 annual report officially disclosed by the company.

　　Japanese fashion executives receive warning letters because of spouse’s short-term transaction.

　　On January 29th, 2024, Shanghai Supervision Bureau of China Securities Regulatory Commission announced that Zhang Yunju, a senior manager of () Group (hereinafter referred to as Nikko Fashion) (chief financial officer and secretary of the board of directors), was suspected of illegal operation, and his spouse Zhang Qingdong had bought 62,200 shares of Nikko Fashion from September 6th, 2023 to October 10th, 2023, with a total amount of 1,064,576. Selling 47,200 shares of the company, with a total amount of 805,565.00 yuan, and holding 15,000 shares as of January 10, 2024, constitutes a short-term trading behavior. In order to maintain market order and regulate illegal trading, according to the relevant provisions of the Securities Law of People’s Republic of China (PRC), Zhang Yunju was taken to issue a warning letter.

　　Pacific Securities: Shareholder Jiayu Investment lifted the waiting freeze on the shares of the company.

　　Pacific Securities announced this evening that the company recently received the Notice of Judicial Freeze and Judicial Transfer of Equity issued by China Securities Depository and Clearing Co., Ltd. Shanghai Branch and the Notice of Assistance in Execution issued by the Haidian District People’s Court in Beijing, and learned that all the shares of the company held by Jiayu Investment were released from the waiting freeze.

　　As of the disclosure date of the announcement, Beijing Jiayu Investment Co., Ltd. ("Jiayu Investment") holds 744 million shares of Pacific Securities, accounting for 10.92% of the company’s total share capital. This time, 744 million shares were released from the waiting list, accounting for 100% of its shares.

　　Pacific Securities said that the lifting of the waiting freeze of Jiayu Investment shares did not have a substantial impact on the company’s operation and corporate governance.

　　Kang Enbei: Repurchase 5,471,800 shares for the first time.

　　On the evening of January 29th, Kang Enbei announced that on January 29th, 2024, the company repurchased 5,471,800 shares of A shares of the company through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 0.21% of the company’s total share capital of 257,037,319 shares. The highest price of the repurchase transaction was 4.7 yuan/share, the lowest price was 4.57 yuan/share, and the total amount of funds paid was 2,526.

　　UFIDA: Accumulated repurchased 34,654,423 shares.

　　On the evening of January 29th, UFIDA announced that as of January 29th, 2024, the company repurchased 4,111,300 shares in January through centralized bidding, and the cumulative number of repurchased shares was 34,654,423 shares, accounting for 1.0137% of the company’s current total share capital, an increase of 0.1202% compared with the last disclosure, and the highest purchase price was 23.39 yuan/share.

　　State Grid Yingda: The company plans to make provision for impairment of 273 million yuan.

　　() According to the announcement, the company held the 12th meeting of the 8th Board of Directors and the 8th meeting of the 8th Board of Supervisors today, and reviewed and approved the Proposal on Provision for Impairment in 2023. In 2023, the company plans to make provision for impairment of 273 million yuan, reducing the profit of consolidated statements in 2023 by 273 million yuan. The financial data related to the provision for impairment has not been audited, and the final accounting treatment is subject to the results confirmed by the annual audit.

　　Goodway: The approval for issuing shares to a specific object expires.

　　Goodway announced that on February 13th, 2023, the company received a reply from China Securities Regulatory Commission, agreeing to the company’s application for registration of issuing shares to a specific target, and the reply will be valid for 12 months from the date of consent to registration (January 31st, 2023). Due to various reasons such as changes in the capital market environment and the timing of issuance, the company failed to implement this non-public offering of shares within the validity period of the approval, and the approval automatically became invalid when it expired.

　　Guobo Electronics: Shareholders promise not to reduce their shares in the company in the next six months.

　　Guobo Electronics announced on the evening of January 29th that its shareholder, CLP Guowei (Tianjin) Integrated Circuit Chip Partnership (Limited Partnership), voluntarily promised not to reduce its shares in the company in any way in the next six months (January 29th to July 28th) from January 29th.

　　Xiao Zhihua, the controlling shareholder of Opmai, completed the increase of 120,600 shares.

　　Opmai announced that Xiao Zhihua, the controlling shareholder, chairman and general manager of the company, increased his holdings of 120,600 shares by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for about 0.1051% of the total issued share capital of the company, and this increase plan has been implemented.

　　Xiangyu, Xiamen: The holding plan of Xiangyu Group, the controlling shareholder, has been implemented.

　　On the evening of January 29th, Xiamen Xiangyu announced that, according to the notice of Xiamen Xiangyu Group Co., Ltd. (hereinafter referred to as "Xiangyu Group"), the controlling shareholder of the company, from October 31st, 2023 to January 29th, 2024, Xiangyu Group increased its holdings of 22,901,069 shares of the company by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for 1% of the company’s issued shares.

　　Yingliu Co., Ltd. plans to set up a joint venture company to engage in the business of fusion reactor materials and components.

　　() Announcement was issued. On January 29th, 2024, the company signed the Sponsor Agreement on the Establishment of Anhui Juneng New Materials Technology Co., Ltd. with Hefei Energy Research Institute Co., Ltd. of Comprehensive Science Center and natural persons Yao Damao, Qi Qiang and Liu Songlin, and planned to jointly contribute to the establishment of a joint venture company to engage in the development, production and sales of fusion reactor materials and components and nuclear detection instruments. The registered capital of the joint venture company is RMB 50 million, of which Yingliu shares intend to contribute RMB 30 million in cash and in kind, making it the largest shareholder of the joint venture company.

　　According to the company, Anhui Juneng New Materials Technology Co., Ltd. was established by the company’s foreign investment this time, with the purpose of rapidly starting the transformation of manufacturing technology of high-heat load components of nuclear fusion devices and technical achievements of shielding materials, and laying a foundation for the company’s long-term development in line with major national strategies in the field of energy equipment.

　　All shares of the company held by Jiayu Investment, a shareholder of Pacific Securities, were released from the waiting freeze.

　　On the evening of January 29th, Pacific Securities announced that the company had recently learned that all the shares of the company held by Beijing Jiayu Investment Co., Ltd. (hereinafter referred to as "Jiayu Investment") had been lifted from the waiting freeze.

　　According to the announcement, Jiayu Investment was sued by Hubei Hump Investment Co., Ltd. to the Haidian District People’s Court in Beijing due to private lending disputes, and all the shares of Pacific Securities held by Jiayu Investment were waiting to be frozen. As of the announcement date, Jiayu Investment holds 744 million shares of Pacific Securities, accounting for 10.92% of the company’s total share capital. This time, the waiting list of frozen shares was lifted by 744 million shares, accounting for 100% of its shares.

　　TBEA: The holding company plans to invest 1.163 billion yuan in Xi ‘an digital factory project.

　　TBEA announced that in order to seize the "double-carbon" market opportunity, expand the production capacity of the company’s inverter and other power electronic products, and improve the company’s competitiveness and profitability in the new energy power electronic equipment market, TBEA Xi ‘an Electric Technology Co., Ltd. ("Xike Company"), the company’s holding company, invested in the construction project of 5G digital factory and science and technology R&D building in Xi ‘an Industrial Park ("Xi ‘an Digital Factory Project"), with a total investment of 1.163 billion yuan and a construction period of 24 months.

　　Zhong Baoshen, chairman of Longji Green Energy, plans to increase its holdings for the first time on January 30.

　　Longji Green Energy announced that Zhong Baoshen, the chairman of the company, plans to increase the company’s shares in a way allowed by the Shanghai Stock Exchange system within 12 months from October 31, 2023, with an increase of not less than RMB 100 million and not more than RMB 150 million. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to implement its first increase on January 30, 2024, and will continue to implement its increase plan.

　　Lexin Technology: It is planned to buy back the company’s shares at a price of 50 million-100 million yuan.

　　Lexin Technology announced on the evening of January 29th that it plans to buy back the company’s shares at a price of 50-100 million yuan, with the repurchase price not exceeding 120 yuan/share. The repurchased shares will be used for employee stock ownership or equity incentive plan.

　　Shaanxi Construction Co., Ltd.: The management adjusted Chen Qi to be the chairman.

　　On the evening of January 29th, () announced that Chen Qi, general manager of Shaanxi Construction Holding Group, was appointed as the chairman of Shaanxi Construction Co., Ltd.. Gao Jiancheng and Yang Haisheng, deputy general managers of Shaanxi Construction Holding Group, are directors of Shaanxi Construction Co., Ltd..

　　It is also known that Zhang Yiguang, the former chairman of Shaanxi Construction Co., Ltd., has served as a counselor of the Shaanxi Provincial Government; Mao Jidong, former vice chairman of Shaanxi Construction Co., Ltd., has served as Party Secretary and Chairman of Shaanxi Construction Holding Group; Mo Yong, the former director and general manager of Shaanxi Construction Co., Ltd., has been transferred to the general manager of Shaanxi Nonferrous Metals Group; Liu Xiaoqiang, the former deputy general manager of Shaanxi Construction Co., Ltd., has been transferred to the general manager of Shaanxi Water Development Group.

　　Design Institute and its subsidiaries have won the bid for several projects.

　　() Announcement, the company and its subsidiaries received the bid-winning notice, and the project names were Anhui () Highway Co., Ltd.’ s 2023 general contracting project of adjusting and refining the design and construction of expressway traffic safety facilities; In 2023, the first bid section of EPC project of new energy projects supporting some expressways in Anhui Province; S40 Section 01 of Ningguo-Jingxian Expressway and S68 Jingde-Jixi Expressway Survey and Design Consulting Service; Design and construction general contracting project of renovation project of Xinqiao International Airport Expressway Monitoring and Management Center Park; Social investor of Xin ‘anjiang tourist channel regulation project franchise project; General contract for design and construction of image reconstruction project of 30 gas stations such as Jiaogang Lake and Lv Wang of Anhui Expressway Petrochemical Co., Ltd.; Special inspection (supervision) service for tunnel of Yongshan-Yanjin Expressway; Central Laboratory of Hefei Section of Huainan-Tongcheng Expressway; Reconstruction and expansion project of Huayang Port Storage Wharf in Wangjiang County-engineering feasibility study and related special topics compilation; Huzhou South Taihu Lake (Xing Wu) General Airport Whole Process Service and Aviation Industrial Park Master Plan Project; Maanshan Expressway Scheme Design Service Procurement Project; Consulting services for site selection and feasibility study of Qingyang General Airport.

　　Crude oil production has reached a new high () It is estimated that the net profit in 2023 will increase by 58.94%-68.88% year-on-year.

　　On the evening of January 29th, Zhongman Petroleum announced the pre-increase of performance, and the company predicted that the net profit attributable to shareholders of listed companies would be 800-850 million yuan in 2023, up by 58.94%-68.88% year-on-year.

　　In 2023, the company focused on Wensu block, aiming at realizing the scale of reserves and rolling production, actively exerting the advantages of integration, and through increasing the combination of exploration and key evaluation, it achieved multiple breakthroughs in new strata and new fields, and basically proved the oil and gas reserves in the upper wall of F1 fault zone in Kekeya Oilfield.

　　At the same time, Wensu Oilfield climbed to a new level on the basis of the accumulated crude oil production exceeding 1 million tons by intensifying the implementation of horizontal wells, actively carrying out reservoir reconstruction measures and strengthening the production management of oil wells, and the annual crude oil production reached a new high in 2023. The company’s Wensu project achieved a crude oil output of 580,800 tons in 2023, an increase of 146,800 tons over the same period of last year, with a year-on-year increase of 33.82%, and continued to maintain a strong growth trend. (Zhao Ping)

　　China Track, the major shareholder of Jinchuang Group, completed the reduction of 3,655,500 shares.

　　() Announcement: China Railway Transportation Co., Ltd. (hereinafter referred to as "China Track"), the non-largest shareholder of the company holding more than 5% of the shares, has reduced its holdings of 3,655,500 shares through centralized bidding and block trading, accounting for 0.47% of the company’s total share capital; As of the disclosure date of this announcement, the time interval of the reduction plan of China Rail, the shareholder of the company, has expired.

　　() The net profit in 2023 was reduced by 5.5 million to 7.5 million yuan, which plunged by 93.11% to 94.95%.

　　Yaxing chemical disclosed the announcement of pre-reduction of annual performance in 2023. The company estimated that the net profit attributable to shareholders of listed companies in the reporting period would be 5.5 million yuan to 7.5 million yuan, a year-on-year decrease of 93.11% to 94.95%. The net loss attributable to shareholders of listed companies after deducting non-recurring gains and losses is 130 million yuan to 90 million yuan, from profit to loss year-on-year.

　　During the reporting period, the company’s production and operation work progressed steadily, and the production capacity continued to show a recovery growth trend since the relocation. However, compared with before the relocation of the company, the depreciation allocation amount of new public works in the factory area was larger; At the same time, during the reporting period, affected by unfavorable factors such as intensified industry competition and weak downstream demand, the net profit after deducting non-recurring gains and losses in 2023 dropped sharply year-on-year.

　　The case of Pacific Securities v. Ningbo Pinbo and other property damages was rejected by the court.

　　On the evening of January 29th, Pacific Securities announced that the company had recently received a Civil Judgment from the Higher People’s Court of Zhejiang Province regarding the company’s case against Ningbo Pinbo Equity Investment Partnership (Limited Partnership), and upheld the original judgment.

　　Pacific Securities said that the creditor’s rights involved in the above cases have been partially paid off, and the company has accrued corresponding asset impairment reserves, which will not have a significant impact on the company’s current profits or future profits. The company’s business operations are normal, and the above litigation matters have no significant impact on the company’s business operations, financial status and solvency.

　　Guojin Securities completed the issuance of 1.5 billion yuan of corporate bonds.

　　On the evening of January 29th, Guojin Securities announced that its corporate bonds with an approved amount of no more than 15 billion yuan (including 15 billion yuan) were approved by Shanghai Stock Exchange and registered by China Securities Regulatory Commission. According to the Prospectus for Offering Corporate Bonds to Professional Investors (Phase I) by Guojin Securities Co., Ltd. in 2024, the issuance scale of Guojin Securities’ offering corporate bonds to professional investors (Phase I) in 2024 shall not exceed RMB 1.5 billion (including RMB 1.5 billion).

　　The bond issuance of this issue ended on January 29th, 2024, and the actual issuance scale was 1.5 billion yuan. In the end, coupon rate was 2.83% and the subscription multiple was 2.64.

　　Year-on-year growth of 14.7 times to 17.6 times. China Ship expects a large increase in net profit in 2023.

　　On the evening of January 29th, China Ship released the announcement of pre-increase of annual performance in 2023. According to the announcement, China Shipbuilding expects the net profit attributable to the owners of the parent company to be between 2.7 billion yuan and 3.2 billion yuan in 2023, up 14.7 times to 17.6 times year-on-year.

　　According to the announcement, the substantial growth of China Ship’s performance in 2023 is mainly affected by the following factors: non-monetary assets exchange gains and losses caused by the disposal of offshore platforms by the company’s subsidiaries and non-recurring gains and losses such as receiving government subsidies; In 2023, the global new shipbuilding market maintained a good development trend as a whole. With the gradual clearing of low-priced ship orders in the early stage, the company’s hand-held order structure continued to improve; Focusing on the annual production task index, the company strengthened production control and improved production efficiency, and its operating income increased significantly year-on-year, exceeding the annual task target.

　　According to the data recently released by the Ministry of Industry and Information Technology, in 2023, China’s three major shipbuilding indicators all increased year-on-year, ranking first in the world for 14 consecutive years. Among them, the shipbuilding completion was 42.32 million deadweight tons, up 11.8% year-on-year; The volume of new orders received was 71.2 million deadweight tons, up 56.4% year-on-year; By the end of 2023, the volume of hand-held orders was 139.39 million deadweight tons, a year-on-year increase of 32.0%.

　　According to industry insiders, since 2023, the price of new ships has continued to rise, and the global new shipbuilding market will remain highly active under the support of updated demand. At the same time, the supply of berths is tight at present, and the competitive characteristics of orders gathering to the head enterprises are obvious, which also gives shipping enterprises a certain bargaining space. It is expected that the price of new ships will continue to remain relatively high in 2024.

　　Three Gorges Energy plans to invest 1 billion yuan with Changjiang Electric Power Co., Ltd. in Tianjin to improve the competitiveness of the regional market.

　　() Announcement: In order to effectively improve the company’s regional market competitiveness in Tianjin and strengthen the overall planning of Tianjin’s regional business, the company plans to establish a joint venture company, Three Gorges Tianjin Energy Investment Co., Ltd. (Tianjin Nengtou, subject to the registered name of the enterprise) with China () Co., Ltd. (referred to as Changjiang Power) and Three Gorges Capital Holding Co., Ltd. (referred to as Three Gorges Capital) in Tianjin, with an all-round layout of its business in Tianjin, focusing on offshore wind power bases around the Bohai Sea. Three Gorges Energy, Yangtze Power and Three Gorges Capital respectively subscribed 510 million yuan, 340 million yuan and 150 million yuan in cash, accounting for 51%, 34% and 15% of the registered capital of the joint venture company respectively.

　　The establishment of Tianjin Energy Investment Co., Ltd. with Changjiang Electric Power and Three Gorges Capital is an important measure to implement the company’s development strategy, which will effectively give full play to the professional capabilities and synergistic advantages of each subject in technology, talent and investment, and provide multiple guarantees and strong support for the high-quality development and construction of Tianjin’s new energy business.

　　Shaanxi Construction Co., Ltd.: Elected Chen Qi as the chairman of the eighth board of directors of the company.

　　On the evening of January 29th, Shaanxi Construction Co., Ltd. announced that on January 29th, 2024, the 16th meeting of the 8th Board of Directors of the Company reviewed and approved the Proposal on Electing the Chairman of the Company. According to the Company Law and the Articles of Association of Shaanxi Construction Engineering Group Co., Ltd., all directors unanimously agreed to elect Chen Qi as the chairman of the eighth board of directors of the company, with a term of office from the date of deliberation and approval at this board meeting to the date of expiration of the eighth board of directors.

　　Three Gorges Energy plans to transfer 100% equity of Urumqi Pumping and Storage Company to Three Gorges Group at a price of 105 million yuan.

　　Three Gorges Energy announced that in order to smoothly promote the preliminary work of Dabancheng Pumped Storage Power Station project in Xinjiang and promote the high-quality development of pumped storage business, it is planned to transfer 100% equity of Three Gorges New Energy Urumqi Pumped Storage Power Generation Co., Ltd. (hereinafter referred to as Urumqi Pumped Storage Company) held by the company to China Yangtze River Three Gorges Group Co., Ltd. (hereinafter referred to as Three Gorges Group) at a price of 105 million yuan.

　　Lexin Technology: The chairman proposed to buy back the company’s shares from 50 million yuan to 100 million yuan.

　　Lexin Technology announced that on January 29, 2024, the board of directors of the company received a letter from TEO SWEEANN (Zhang Ruian), the controlling shareholder, actual controller and chairman of the company, on proposing Lexin Information Technology (Shanghai) Co., Ltd. to buy back the shares of the company. TEO SWEE ANN proposed that the company buy back the company’s shares through centralized bidding transaction for employee stock ownership or equity incentive plan. The total amount of repurchase funds is not less than 50 million yuan and not more than 100 million yuan; The repurchase price shall not exceed 120 yuan/share.

　　Lexin Technology said that TEO SWEE ANN proposed to buy back shares through centralized bidding transaction based on its confidence in the company’s future sustainable development and recognition of the company’s value, in order to safeguard the interests of investors, enhance investors’ confidence in the company’s investment, and promote the stable and healthy development of the company, effectively combining the interests of shareholders, the company’s interests and the personal interests of employees.

　　Shengtun Mining expects to make provision for impairment of 306 million yuan in 2023.

　　() Announcement, the company’s provision for impairment this time is included in the subjects of asset impairment loss and credit impairment loss. The total impact on the company’s total consolidated profit in 2023 is-306 million yuan (unaudited).

　　Lexin Technology: It is planned to buy back shares at a price of RMB 50 million to RMB 100 million.

　　Lexin Technology announced that the company intends to buy back shares by centralized bidding transaction for employee stock ownership or equity incentive plan. The repurchase amount is not less than 50 million yuan and not more than 100 million yuan; The repurchase price shall not exceed 120 yuan/share.

　　TBEA: The holding company plans to invest in Xi ‘an digital factory project.

　　TBEA announced that TBEA Xi ‘an Electric Technology Co., Ltd., the company’s holding company, plans to invest in the construction project of 5G digital factory and science and technology research and development building in Xi ‘an Industrial Park, with a total investment of 1,163,244,400 yuan.

　　Ji Xiang shares’ pre-loss performance in 2023 both declined.

　　() On the evening of January 29th, the announcement of pre-loss of annual performance in 2023 was released. The company expects to achieve a net profit of-270 million yuan to-340 million yuan in 2023, compared with 492 million yuan in the same period of last year; It is estimated that the non-net profit deducted in 2023 will be-290 million yuan to-370 million yuan, compared with 435 million yuan in the same period of last year.

　　As for the main reason for the pre-loss of performance, Ji Xiang said that in 2023, due to the slowdown in the growth rate of the new energy vehicle market, the upstream resource supply capacity was released, the price of lithium salt fell all the way, and the industry as a whole was in a downturn. Yongshan Lithium Industry actively takes measures to reduce the risks brought by the market downturn by accelerating shipment, increasing the proportion of processing business and purchasing lithium ore at the right time. Among them, the lithium salt plate achieved profitability in the first quarter of 2023. Since the second quarter of 2023, the competition in the lithium salt market has intensified, and the sales volume is less than expected at the beginning of 2023. At the same time, the rapid decline in the unit price of products has led to a low gross profit margin of products, which has led to a loss in the lithium salt sector business throughout the year. During the reporting period, the lithium sector is expected to achieve a net profit of-120 million yuan to-160 million yuan.

　　In addition, the company’s molybdenum plate business was affected by the deep and frequent fluctuations in the prices of products and raw materials, and the gross profit margin of products was low, and the inventory depreciation loss increased, resulting in a large loss in the company’s molybdenum business.

　　Ji Xiang Co., Ltd. was originally a large-scale molybdenum enterprise. Influenced by macroeconomic fluctuations, changes in upstream and downstream market demand and other factors, the molybdenum industry fluctuated greatly, which led to great fluctuations in the company’s performance. Based on this background, Ji Xiang has tried to enter a new field in recent years.

　　In January 2022, Ji Xiang Co., Ltd. completed the acquisition of the equity of Yongshan Lithium Industry, actively strategically laid out the lithium salt business, and increased the lithium industry sector in its main business. At the end of June, 2022, the first-phase project of Yongshan Lithium Industry was put into operation. In October of the same year, the annual production capacity of 15,000 tons of battery-grade lithium hydroxide and 10,000 tons of battery-grade lithium carbonate was formed, and the core cathode materials were supplied to customers in batches. The second phase of the project was officially started in April 2023.

　　It should be pointed out that in the first half of 2023, Ji Xiang’s share performance turned a profit year-on-year, which was mainly due to the contribution of the lithium salt sector. However, the third quarterly report of Ji Xiang Co., Ltd. in 2023 showed that the company’s net profit suffered a loss of 196 million yuan due to the sharp drop in the price of lithium salt products and the huge fluctuation in the market price of molybdenum products.

　　On the evening of October 20, 2023, Ji Xiang Co., Ltd. announced the abnormal fluctuation of stock trading. The operating period of the company’s lithium sector was short, the competition pattern of the lithium industry was fierce, and the overall price of lithium products fluctuated greatly, which led to operational risks in the industry.

　　It is worth mentioning that Yang Feng, chairman and general manager of Ji Xiang Co., Ltd., said at the performance briefing in 2022 that the operation of molybdenum industry is indeed inefficient compared with that of lithium industry, but at this stage it accounts for a relatively high proportion of overall revenue. At present, it will still maintain the pattern of dual main businesses. After the revenue proportion of lithium industry rises, it will consider making appropriate arrangements and adjustments to molybdenum industry at the right time.

　　As early as September 2022, Ji Xiang announced that it would sell its 100% equity of Xisha Degai Molybdenum Industry, a wholly-owned subsidiary, to Shanghai Yongju, a wholly-owned subsidiary of Ningbo Jutai, the controlling shareholder of the company, for 580 million yuan in cash. The business scope of Xisha Degai Molybdenum Industry includes molybdenum mining and dressing (subject to the validity of mining license) and sales of molybdenum products.

　　Ji Xiang said that after the completion of the above transaction, the company will further focus on the processing and production of lithium salt and molybdenum products, optimize the company’s business and product structure, promote the positive transformation of the company’s business, and improve the company’s anti-risk ability and sustainable profitability.

　　According to the announcement of Ji Xiang on November 10, 2023, as of November 9, 2023, Shanghai Yongju has paid off the above-mentioned 580 million yuan equity transfer and paid the corresponding overdue interest.

　　Strong demand for photovoltaic brackets. CITIC Bo’s net profit in 2023 is expected to increase by nearly 7 times.

　　On the evening of January 29th, CITIC Bo announced that, according to the preliminary calculation of the financial department, it is estimated that the annual net profit in 2023 will be about 354 million yuan, an increase of about 310 million yuan, an increase of about 696.70%. Deducted non-net profit was about 313 million yuan, an increase of about 2270.60% year-on-year.

　　According to the data, CITIC Bo’s main business is the design, research and development, production and sales of photovoltaic bracket systems. Last year, as an important part of the photovoltaic industry, the market demand for photovoltaic brackets continued to expand with the growth of photovoltaic installed capacity.

　　For performance growth, CITIC Bo said that the global market for photovoltaic centralized ground power stations has strong demand for new installed capacity, and the company has a leading comprehensive advantage in the field of photovoltaic bracket system segmentation. At the same time, relying on the advantages of the global marketing service network and efficient supply and delivery system, the company’s photovoltaic bracket product business has developed rapidly, achieving double growth of the company’s operating income and net profit.

　　At the same time, CITIC Bo said that the company’s previous strategic layout in the photovoltaic bracket industry gradually showed results in 2023, and orders also increased, effectively supporting the growth and sustainability of the company’s main business. As of December 31, 2023, the company’s orders in hand totaled about 4.7 billion yuan, including about 3.6 billion yuan for tracking system, 1 billion yuan for fixed bracket and 100 million yuan for others.

　　As for the substantial increase in non-net profit deduction, CITIC Bo explained that during the reporting period, the non-operating profit and loss increased compared with the same period of last year due to the influence of changes in the fair value of transactional financial assets (forward foreign exchange locking business), government subsidies included in the current profit and loss, the profit and loss of assets entrusted by others to invest or manage, and the reversal of impairment provision for receivables that were separately tested for impairment.

　　It is worth mentioning that in 2023, CITIC Bo also strengthened cooperation with well-known photovoltaic enterprises at home and abroad, and further expanded its market share through cooperative research and development and joint promotion. At the same time, actively lay out overseas markets, set up overseas subsidiaries and establish sales channels.

　　Recently, CITIC Bo announced that the company has signed a strategic cooperation agreement with Alpon Energy in Turkey. In the future, the two sides will cooperate in photovoltaic power plant project management, technical service cooperation, product installation and commissioning in the local market to ensure the full-cycle operation of CITIC Bo’s projects in the Turkish market and deepen the Turkish renewable energy market. Through the signing of this strategic cooperation agreement, the two sides will jointly promote the common growth of the solar energy market in Turkey and its neighboring countries in the future.

　　Recently, CITIC Bo has publicly stated that at present, CITIC Bo has four manufacturing bases around the world, with an annual delivery capacity of 30GW. At present, its products have served more than 1,500 projects in more than 40 countries. In 2024, CITIC Bo will continue to improve product and supply security, promote supply-side structural reform and promote economic development.

　　From the perspective of the secondary market, the photovoltaic sector has recently ushered in a sustained rebound. Industry analysis believes that the main reason is that the recent overseas PV inventory has been significantly reduced. () According to the research report, it is estimated that the new installed capacity of photovoltaic in China will increase by about 15% in 2024. The overseas market demand is expected to be fully stimulated by the drop in component prices. It is estimated that the installed capacity will increase by 465-485 GW, up by about 20% year-on-year. Hua Fu Securities believes that the triple efforts of China, the United States and Europe are accompanied by the rapid growth of emerging markets. It is estimated that the installed photovoltaic capacity in the world will be 470GW in 2024, with a year-on-year growth rate of 24%, and the demand is still resilient.

　　Sifang Technology: It is planned to issue convertible bonds not exceeding RMB 1.023 billion.

　　() Announcement, the company plans to issue convertible bonds to unspecified objects, with the total amount of funds raised not exceeding 1,023,395,000 yuan, and plans to invest in the project of enhanced polyurethane cryogenic composite materials for LNG thermal insulation system, the production project of special tank storage and transportation equipment, and the construction project of green and energy-saving new materials engineering technology research center.

　　Heideman, Zhejiang: It is estimated that the performance in 2023 will be announced.

　　Zhejiang Heideman announced that the company is conducting preliminary accounting for its performance in 2023, and the specific financial data will be published after being audited by certified public accountants. During the reporting period, the company increased the iterative upgrade of products, and sold some stock models through promotion, which had an impact on the gross profit margin. At the same time, the company has also increased its market development and maintenance efforts, and the exhibition and publicity expenses have increased year-on-year. In order to develop high value-added products, the company’s R&D personnel recruitment and R&D expenditure increased year-on-year. The above forecast data are only preliminary accounting data, and the specific and accurate financial data are subject to the audited 2023 annual report officially disclosed by the company.

　　Longji Green Energy: The chairman of the board plans to increase its holdings for the first time on January 30th.

　　Longji Green Energy announced that the company had previously announced that Chairman Zhong Baoshen planned to increase the company’s shares within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to increase its holdings for the first time on January 30, 2024, and will continue to increase its holdings according to the above increase plan.

　　Witten Electric’s main business is steadily improving, and its net profit in 2023 increased by 57.34% to 74.50% year-on-year.

　　On the evening of January 29th, Witten Electric announced the pre-increase announcement of its annual performance in 2023. The company predicted that the net profit attributable to the owners of the parent company would reach 110 million yuan to 122 million yuan this year, which will increase by 40,087,000 yuan to 52,087,000 yuan compared with the same period of last year, with a year-on-year increase of 57.34% to 74.50%. It is estimated that the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses will reach 98 million yuan to 110 million yuan in 2023, which will increase by 31,694,900 yuan to 43,694,900 yuan compared with the same period of last year (legally disclosed data), with a year-on-year increase of 47.80% to 65.90%.

　　The announcement shows that during the reporting period, the company’s business developed steadily and the overall development trend was good. The company closely focuses on the three major businesses of power distribution equipment, new photovoltaic materials and energy storage systems, and constantly consolidates the industrial development layout. On the basis of the gradual improvement of production capacity, we will continue to increase investment in research and development, product development, strengthen the construction of sales team and strengthen market promotion.

　　It is reported that the sales of main products of Witten Electric, such as high and low voltage bus, pv ribbon and energy storage system, increased, which promoted the steady growth of the company’s operating performance.

　　Longji Green Energy: the concerted action of the controlling shareholder received the advance notice of administrative punishment.

　　Longji Lvneng announced on the evening of January 29th that Li Chun ‘an, the concerted action person of the company’s controlling shareholder, received the Notice of Administrative Punishment in advance issued by Liaoning Securities Regulatory Bureau on January 29th. As the chairman of Liancheng CNC, the target of Shijin Technology’s fixed issuance, Li Chun ‘an leaked inside information to Zhao Mouping before the inside information was made public, which constituted an act of leaking inside information. Liaoning Securities Regulatory Bureau plans to make the following decision: impose a fine of 500,000 yuan on Li Chun ‘an. Longji Green Energy said that the subject of punishment involved in the above-mentioned "Notice of Administrative Punishment in advance" is only Li Chun ‘an, and the subject of insider trading involved in the matter of punishment is not the company’s stock, and it does not involve related matters of the company. The above administrative penalties will not affect the normal operation, standardized operation and financial status of the company.

　　Huitong shares: In 2023, the non-net profit was pre-increased by 236.34%-297.07%, and the income in new markets increased steadily.

　　On the evening of January 29th, Huitong announced the pre-increased performance, and it is estimated that the net profit returned to the mother will reach 143 million yuan to 161 million yuan in 2023, an increase of 141.50% to 172.52% compared with the same period of last year (legally disclosed data). It is estimated that the net profit of non-returning to the mother will be 102 million yuan to 120 million yuan, an increase of 236.34% to 297.07% over the same period of last year.

　　According to the announcement, the main reason for the growth of Huitong’s performance in 2023 is that the company seized the opportunity of macro-market structural adjustment, continued to increase investment in new markets such as new energy vehicles and consumer electronics, and achieved steady growth in income in related fields. The change in market structure promoted the company’s high-quality development and at the same time promoted the overall profit growth of the company. At the same time, by focusing on the application scenarios of major customers, the company effectively solved the pain points of customers, increased investment in innovative research and development, strengthened the improvement of product strength and solution capability, promoted the iterative innovation of products in the company’s advantageous business areas, and developed a number of products with leading industry and stable quality, which drove the growth of the company’s profits. In addition, the company adheres to the concept of achieving customers, promotes customer-oriented value flow carding, realizes efficiency improvement in the whole value chain operation, and at the same time comprehensively introduces the concept of lean, promotes cost reduction for all employees, and further enhances the company’s profitability.

　　Huitong Co., Ltd. is mainly engaged in the research and development, production and sales of polymer modified materials, and strategically laid out the new energy sector business, and built a wet separation film project for lithium batteries with an annual output of 1.7 billion square meters.

　　At present, China’s high-end modified materials market is still dominated by imports. In order to break the monopoly in the field of special engineering materials and realize the goal of import substitution, Huitong Special Materials Technology Co., Ltd. was established by foreign investment to build an integrated platform of "polymerization-modification" of special engineering materials. The company’s special engineering materials have been mass-produced and sold, and the annual production capacity of polymer products can reach 3,000 tons. At the same time, the company vigorously carried out the research and development of international high-end modified materials, and developed a number of imported substitute products, including long carbon chain nylon for the surface coating of dishwasher bowls and baskets; PPS, a special engineering material with excellent properties such as high strength and creep resistance, has reached CTI0 level. Flame retardant PC and alloy materials with good high and low temperature toughness, outdoor aging resistance and solvent stress cracking resistance.

　　In addition to increasing research and development efforts to achieve import substitution, the company also seized the opportunity of high-quality development and green low-carbon cycle transformation, and actively practiced the strategy of green design and green intelligence to create low carbon. Comprehensively promote the layout of the whole industrial chain of PCR products, carry out strategic cooperation with upstream suppliers such as zero-carbon products, continuously expand the use of PCR modified plastics, complete the certification of recycled materials content of more than 100 products, obtain OBP certification, provide product carbon accounting support for many customers, and continuously promote the construction of the company’s product carbon accounting database.

　　In addition, the company continues to optimize and upgrade MES, QMS and WMS systems to promote standardization, transparency and dataization of production processes; Through the optimization of manufacturing production line and the promotion of three-dimensional library project, the company has continuously improved its intelligent manufacturing management level, realized the intelligent collaboration of man-machine material method ring, and achieved multiple goals such as efficiency improvement and cost reduction.

　　Based on the business data platform, the company has built four platforms, namely, customer service, R&D management, order delivery and business analysis, to realize the visualization of the whole LTC process and promote the company’s new breakthrough from "manufacturing" to "intelligent manufacturing". (Qi Hening)

　　Fulai New Material Yantai Fuli Phase I (Second Line) Project entered trial production.

　　() On the evening of January 29th, it was announced that the second production line of Yantai Fuli New Materials (Phase I) project invested and built by the holding subsidiary had completed the equipment installation and commissioning and entered the trial production stage.

　　Yantai Fuli New Materials (Phase I) Project has an annual production capacity of about 100,000 tons of BOPP functional films. The first production line of the project was successfully put into production in July 2023, with a designed annual production capacity of about 50,000 tons of BOPP functional films, which has reached the designed production capacity. At present, the second production line of the project has completed the equipment installation and debugging, and entered the trial production stage, with the designed annual production capacity of about 50,000 tons of BOPP functional film.

　　Fulai New Materials’ main business is functional coating composite materials, which are mainly divided into three categories: advertising inkjet printing materials, label printing materials and electronic functional materials. Yantai Fuli New Materials’ main business is film research and development, production and sales.

　　According to the announcement, after the project is fully put into production, the company’s comprehensive cost and raw material supply will be further reduced, which will have a positive impact on the company’s future operating performance and further stabilize the company’s dominant position in the industry. (Wang Weili)

　　() The net profit in 2023 was reduced by 14 million yuan to 21 million yuan, which plummeted by 93.34% to 95.56%.

　　Suli shares disclosed the announcement of pre-reduction of 2023 annual results. The company expects that the net profit attributable to shareholders of listed companies during the reporting period will be 14 million yuan to 21 million yuan, a year-on-year decrease of 93.34% to 95.56%. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 15 million yuan to 22.5 million yuan, a year-on-year decrease of 92.78% to 95.19%.

　　In 2023, the main reason for the decrease in performance compared with the same period was: due to the cyclical fluctuation of the industry and changes in market supply and demand, the market price of the company’s main products continued to be at a low level and the sales of some products declined, which led to the decline in the profit margin of the company’s products.

　　Chairman Longji Green Energy plans to increase its holdings for the first time on January 30th.

　　Longji Green Energy announced that the company had previously announced that Chairman Zhong Baoshen planned to increase the company’s shares within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to increase its holdings for the first time on January 30, 2024, and will continue to increase its holdings according to the above increase plan.

　　[Company Report]

　　Weilai signed a strategic cooperation agreement with Longji Green Energy

　　According to Weilai Guanwei news, on January 3, Weilai and Longji Green Energy jointly announced the signing of a strategic cooperation agreement. The two sides will work closely together to promote the use of green and clean energy for photovoltaic power generation in charging and replacing power stations, build an industry-leading integrated station for optical storage, charging and replacing, and cooperate in promoting the interaction between distributed photovoltaic and V2G vehicle network, and establishing relevant industry standards of "carbon neutrality in travel".

　　Weilai holds hands with Longji Green Energy to promote photovoltaic power exchange station.

　　Weilai’s pace of foreign cooperation is quietly accelerating. Following the establishment of "Power Exchange Partners" with Changan and Geely, Weilai has recently extended its cooperation tentacles to the leading photovoltaic industry.

　　On January 3rd, Weilai (09866) and Longji Green Energy jointly announced the signing of a strategic cooperation agreement. The two sides will work closely together to promote the use of green and clean energy for photovoltaic power generation in charging and replacing power stations, build an industry-leading integrated station for optical storage, charging and replacing, and cooperate in promoting the interaction between distributed photovoltaic and V2G vehicle networks, and establishing relevant industry standards for "carbon neutrality in travel" to help realize the goal of "peak carbon dioxide emissions and carbon neutrality" in the transportation field. (Securities Times Han Zhongnan)

　　ST Tiancheng received the inquiry letter of performance forecast.

　　() According to the announcement, on January 29th, 2024, it received the "Letter of Inquiry on Matters Related to the Performance Forecast of Guizhou Changzheng tiancheng holdings Co., Ltd." issued by Department II of Listed Company Management of Shanghai Stock Exchange.

　　In the fourth quarter, Anhui Construction Engineering Co., Ltd. signed a new contract worth 49.55 billion yuan, a year-on-year increase of 31.95%.

　　() Announcement: In the fourth quarter of 2023, the company signed 133 new contracts, with a new contract amount of 49.55 billion yuan, with a year-on-year increase of 31.95%. From the first quarter to the fourth quarter of 2023, a total of 551 new contracts were signed, with a new contract value of 151.07 billion yuan, an increase of 13.81% year-on-year.

　　Anhui Construction Engineering Subsidiary won several projects.

　　Anhui Construction Engineering announced that recently, the company’s subsidiaries Anhui Highway and Bridge Engineering Co., Ltd., Anhui Construction Engineering Sanjian Group Co., Ltd., Anhui Water Resources Development Co., Ltd., Anhui Construction Engineering Transportation and Navigation Group Co., Ltd. and Anhui Sanjian Luzhou Engineering Co., Ltd. received the bid-winning notice.

　　It is reported that the bid-winning projects are bid YQB2(YQTJ-02) of subgrade and pavement construction in Anqing-Qianshan section (Yueshan-Qianshan section) of S22 Tiantian Expressway; New Development Bank loans the second phase (K5+800-K10+860) of the new construction project of S334 Eshan Road East Extension (Yanjiang Expressway to Wuxuan Expressway) of Anhui Highway Development Project; Hefei Future Great Science City Area Project (Phase I) integrates investment, construction and operation; Construction of Lanyuan Yuefu Project; S18 Bid Section -4 of Subgrade and Pavement Project of Hefei Section of Nanjing-Hefei Expressway.

　　() The net profit in 2023 was reduced by 420 million yuan to 500 million yuan, plunging by 67.99% to 73.11%.

　　Blum Oriental disclosed the announcement of pre-reduction of 2023 annual results. The company expects the net profit attributable to shareholders of listed companies to be 420 million yuan to 500 million yuan during the reporting period, down 67.99% to 73.11% year-on-year. The net profit attributable to shareholders of listed companies, after deducting non-recurring gains and losses, ranged from-20 million yuan to-10 million yuan, turning from profit to loss year-on-year.

　　It is reported that the pre-reduction of the company’s performance is mainly due to the increasing downward pressure of the global economy in 2023, the continued sluggish downstream consumer demand, and the impact of overseas clothing brands’ destocking. The company’s overall orders are insufficient, the capacity utilization rate declines, and the product price declines year-on-year, resulting in a decline in the profit of the company’s main business.

　　Chengdu Gas Company, which secretly set up concealed pipes to discharge water pollutants, received the decision of administrative punishment.

　　() A few days ago, it was announced that Chengdu Liquefied Natural Gas Co., Ltd. (hereinafter referred to as "Liquefied Company"), a wholly-owned subsidiary of the company, received the administrative penalty decision issued by Chengdu Ecological Environment Bureau on January 25, 2024.

　　The Chengdu Bureau of Ecology and Environment conducted a law enforcement inspection on the "Sichuan Tire and Rubber (Group) Co., Ltd. Natural Gas Distributed Energy Project" of Liquefied Company, and found that the Liquefied Company discharged water pollutants in the project. According to the fourth paragraph of Article 42 of People’s Republic of China (PRC) Environmental Protection Law and Article 39 of People’s Republic of China (PRC) Water Pollution Prevention Law, Chengdu Eco-environment Bureau fined the liquefaction company 177,100 yuan.

　　According to official website of Chengdu Ecological Environment Bureau, on August 31st, 2023, the law enforcement officers of Longquanyi detachment of Chengdu Ecological Environment Protection Comprehensive Administrative Law Enforcement Corps conducted a law enforcement inspection on "Sichuan Tire & Rubber (Group) Co., Ltd. Natural Gas Distributed Energy Project" of Chengdu LNG Co., Ltd. located at No.568, Chuanxiang Road, Yangma Street, East Chengdu New District, according to the double random clues, and found that the liquefaction company had committed the following environmental violations: discharging water pollutants by means of evading supervision.

　　() The net profit in 2023 was reduced by 80 million to 110 million yuan, which plunged by 83.67% to 88.13%.

　　Changyuan Group disclosed the announcement of pre-reduction of annual performance in 2023. The company expects the net profit attributable to shareholders of listed companies to be 80 million yuan to 110 million yuan during the reporting period, a year-on-year decrease of 83.67% to 88.13%. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 50 million yuan to 74.5 million yuan, a year-on-year decrease of 0.36% to 33.13%.

　　During the reporting period, while consolidating the market position of the main network business, it continuously explored new markets at home and abroad, and its operating income grew steadily, increasing by about 900 million yuan compared with the same period of last year, mainly due to the increase in sales income of smart grid equipment and new energy projects, especially engineering general contracting business. In addition, the investment income decreased by about 1.16 billion yuan compared with the same period of last year.

　　() A shareholders’ meeting will be held on February 19th to consider the proposal that the controlling shareholders provide new loans and related transactions to the holding subsidiaries of the company.

　　Samsung New Materials announced that the first extraordinary shareholders’ meeting will be held on February 19, 2024, and online voting will be held on the same day. Date of record falls on February 2nd, and investors who hold shares of Samsung New Materials can vote after the market closes on that day.

　　Meeting place: meeting room on the third floor of Zhejiang Samsung New Materials Co., Ltd., No.333 Hanghai Road, Yuyue Town, Deqing County, Huzhou City, Zhejiang Province.

　　A total of 1 proposal was audited at this general meeting of shareholders, as follows:

　　1. Proposal on Providing New Loans and Related Transactions to the Company’s Holding Subsidiaries by Related Parties of the Controlling Shareholders.

　　Baosteel packaging: It is planned to buy back shares at a price of RMB 50 million to RMB 100 million.

　　On January 29th, baosteel packaging announced that it plans to buy back its shares at a price of 50-100 million yuan, which will be used for the continuous implementation of the equity incentive plan in the future. The upper limit of the repurchase price is planned not to exceed 7.66 yuan/share.

　　Baosteel packaging: It is planned to buy back the company’s shares of RMB 50 million to RMB 100 million.

　　Baosteel packaging announced that it plans to buy back 50-100 million yuan of shares of the company, which will be used for the continuous implementation of the equity incentive plan in the future, and the repurchase price will not exceed 7.66 yuan/share.

　　Eco-Optoelectronic Power Co., Ltd. pre-reduced its net profit by 12 million to 18 million yuan in 2023, plummeting by 74.40% to 82.94%.

　　Eko Optoelectronics disclosed the announcement of pre-reduction of 2023 annual results. The company expects the operating income in the reporting period to be 220 million yuan to 250 million yuan, a year-on-year decrease of 4.82% to 16.24%. The net profit attributable to the owners of the parent company was 12 million yuan to 18 million yuan, a year-on-year decrease of 74.40% to 82.94%. The net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was 6 million yuan to 9 million yuan, a year-on-year decrease of 84.59% to 89.73%.

　　It is reported that due to various factors such as the global economic slowdown, the overall macro-economy and the cyclical changes of lithium batteries, customer demand has declined, the company’s orders have decreased and industry competition has intensified, resulting in a decline in the company’s sales and gross profit margin. In addition, during the reporting period, the expenses for renovation and renovation of newly leased production and office buildings and investment in new production line equipment increased related expenses and fixed costs; In order to maintain the company’s competitive advantage in the market, the company continues to carry out technological innovation and constantly explore market areas and customer groups, resulting in an increase in the company’s research and development expenses and operating costs; In the first half of 2023, new equity incentives were added, and the relevant share payment fees were confirmed.

　　Lexin Technology completed the repurchase of 1.06% shares at a cost of 80,025,900 yuan.

　　Lexin Technology announced that as of January 29, 2024, the company had repurchased 858,100 shares of the company through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 1.06% of the company’s total share capital of 80,789,724 shares. The highest price of the repurchase transaction was 100.00 yuan/share, and the lowest price was 81.61 yuan/share, and the total amount of funds paid was 8,002.50 yuan. The amount of shares repurchased this time has reached the upper limit, and the repurchase plan has been implemented.

　　China Ship is expected to have a net profit of 2.7 billion yuan to 3.2 billion yuan in 2023, with an explosive increase of 1470.95% to 1761.87%.

　　According to the announcement of the pre-increase of the annual performance of China Shipbuilding Co., Ltd. in 2023, the company expects the net profit attributable to the owners of the parent company to be between 2.7 billion yuan and 3.2 billion yuan, increasing by 1470.95% to 1761.87% year-on-year. It is estimated that the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses will be between-500 million yuan and 0 yuan in 2023.

　　During the reporting period, due to the exchange gains and losses of non-monetary assets arising from the disposal of offshore platforms by subsidiaries of the company and the receipt of government subsidies, the company’s non-recurring gains and losses in this period were about 3.2 billion yuan, compared with 2.921 billion yuan in the same period of last year; At the same time, in 2023, the global new shipbuilding market maintained a good development trend as a whole. With the gradual clearing of low-priced ship orders in the early stage, the company’s hand-held order structure continued to improve; Focusing on the annual production task index, the company strengthened production control and improved production efficiency, and its operating income increased significantly year-on-year, exceeding the annual task target. Due to the comprehensive influence of the above factors and the low performance index of the company in the same period of last year, the company’s performance in this period has increased significantly compared with the same period of last year.

　　Some directors and senior executives of Shengmei Shanghai increased their holdings by 95,700 shares.

　　Shengmei Shanghai announced that by January 29th, 2024, the company’s directors, general manager Wang Jian, deputy general manager Chen Fuping and secretary of the board of directors Luo Mingzhu had increased their holdings of 95,700 shares by centralized bidding through the trading system of the Shanghai Stock Exchange, accounting for 0.0220% of the company’s total share capital, with a total increase of 7,754,800 yuan, which has exceeded 50% of the lower limit of 9 million yuan in this increase plan. The increase plan has not yet been implemented.

　　The film market recovers. Hengdian Film and Television is expected to turn a profit in 2023.

　　On the evening of January 29th, () announced that it is estimated that the net profit attributable to shareholders of listed companies will be 135 million yuan to 180 million yuan in 2023, which will turn losses into profits.

　　As for the main reasons for the pre-earnings, Hengdian Film and Television said that in 2023, the operating environment of the cinema industry improved, the national film market recovered, the supply side, the projection side and the demand side all improved significantly compared with the same period of last year, the high-quality content continued to be supplied, and the normal pace of film booking and announcement was maintained. The box office performance in the Spring Festival and summer slots was outstanding, the audience’s demand for watching movies was released, the number of people watching movies and the attendance rate increased, and the company’s projection business income and others increased.

　　Xiang Kai, a young playwright and director in China, said in an interview with Securities Daily: "It is expected that the market will show a strong recovery in 2024, and it is expected to usher in a peak."

　　In the context of the rising market boom and the continuous concentration of the industry, Hengdian Film and Television said at a recent performance briefing: "The company has established a good strategic cooperative relationship with well-known commercial real estate companies and commercial management companies, and has sufficient cinema project reserves. It plans to build 30 to 50 new direct-operated cinemas every year. By enhancing the brand influence of Hengdian Film and Television, we will improve the service quality of Hengdian Cinema, strengthen the publicity of the resource advantages of Hengdian Cinema and attract more cinemas to join Hengdian Cinema. "

　　In addition, from the perspective of its own development, in 2023, Hengdian Film and Television will strengthen its management, continue to reduce costs and increase efficiency, strengthen internal control and enhance its comprehensive competitiveness. The operation of the projection business and the content sector is improving.

　　In fact, in recent years, the company has made great efforts to expand to the upstream of the industrial chain, and made great efforts to produce content and produced a large number of high-quality works. In 2023, Zhejiang Hengdian Film Co., Ltd. (hereinafter referred to as "Hengdian Film"), a wholly-owned subsidiary of Hengdian Film, participated in the production of films such as Wandering Earth 2 and Keeping You Safe, which were released in major schedules and achieved good social and economic benefits.

　　"In recent years, Hengdian Film and Television has actively transformed into content output, and its development has advanced by leaps and bounds, and it has achieved good results in film production and distribution." Xiang Kai said.

　　As the Spring Festival approaches, a number of domestic films are scheduled to be released in the Spring Festival file one after another, including three films produced by Hengdian Film Co., Ltd., Pegasus 2, Bears Coming and Going, Reversing Time and Space, and Viva La Vida. Pegasus 2 has been predicted as the box office champion of this Spring Festival file by many film critics.

　　Feng Yangyang, an expert on communication planet App, told the Securities Daily reporter: "Hengdian Film and Television emphasizes high-quality content in its distribution business, which is in line with the demand for high-quality works in the current film market. In recent years, the company has successfully launched a number of high-quality films, accumulating a good reputation and market influence. In the future development, Hengdian Film and Television is expected to continue to maintain its growth momentum and its market share is expected to further expand. "

　　It is reported that Hengdian Film and Television still reserves a number of investment films, and constantly strengthens the synergy between the content plate and the cinema plate, and invests in high-quality film and television projects with the help of professional perspectives and the advantages of cinema channels.

　　Chairman Longji Green Energy plans to implement the first increase in holdings today.

　　On the evening of January 29th, Longji Green Energy announced that on January 29th, the company received a notice from Chairman Zhong Baoshen that it planned to increase its holdings for the first time on January 30th, 2024, and will continue to implement its holdings plan.

　　According to the previous disclosure, Zhong Baoshen plans to increase the company’s shares in a way allowed by the Shanghai Stock Exchange system within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan.

　　"At present, both the price of the photovoltaic industry chain and the performance of the secondary market are in the downward stage. Longji Green Energy is the leader of the photovoltaic industry, and its chairman’s increase in holdings has obviously boosted the industry." Dr. Ding Bingzhong, a partner of Shanghai Jimao Assets, told the Securities Daily reporter.

　　According to the performance forecast recently released by listed companies in the photovoltaic industry chain, the performance of many listed companies declined in the fourth quarter of last year, among which the silicon wafer leader () is expected to lose 1.388 billion yuan to 1.988 billion yuan in the fourth quarter of last year.

　　"Since 2023, the prices of products in all aspects of the photovoltaic industry chain have continued to decline, especially in the second half of the year. The prices of silicon materials, silicon wafers and components have fallen sharply. Although the installed capacity increased substantially last year, the profits of the industry chain have been severely squeezed." Wang Tieshan, director of the Industrial Development and Investment Research Center of Xi ‘an Engineering University, said in an interview with a reporter from Securities Daily.

　　Longji Green Energy recently said in an institutional survey that from the fourth quarter of 2023 to the present, the price of the photovoltaic industry chain has dropped to a very irrational position, which is not conducive to the long-term healthy development of the photovoltaic industry.

　　According to the reporter, with the continuous decline in the price of photovoltaic industry chain, some enterprises have begun to control production and reduce production.

　　"From the current situation, the intensified market competition caused by staged overcapacity will continue for some time. Some enterprises with insufficient cost control ability and backward production capacity will face the risk of being eliminated, while some enterprises with advantages in technology and cost control will be more competitive, which is conducive to the healthy development of the industry." Wang Tieshan said.

　　Longji Green Energy said that since the fourth quarter of 2023, enterprises in different manufacturing sectors have announced the pace of delaying production expansion. If the profit pressure of the industry continues, there may be a general phenomenon of delaying production expansion, which can restrain the escalation of oversupply pressure to some extent. At the same time, the iteration of battery technology is accelerated, and new technologies such as TOPCon and BC are accelerating to replace P-type PERC technology, and the corresponding backward production capacity will also be cleared, which will promote the gradual improvement of the supply and demand pattern of the industry.

　　"After the price of the industrial chain has been falling all the way, some enterprises will inevitably withdraw from the industry or reduce production. As the industry leader, Longji Green Energy has obvious competitive advantages and is expected to usher in new development opportunities and its fundamentals will be improved. " Ding Bingzhong analyzed that this may also be the confidence of its chairman in this increase.

　　"From the historical experience, the development of the photovoltaic industry is characterized by periodic fluctuations, so after a period of trough, it is expected to usher in new development opportunities. As the global attention to renewable energy continues to increase, the demand for photovoltaic market is expected to continue to grow. " Zhu Keli, executive director of China Information Association, said in an interview with a reporter from Securities Daily.

　　The controlling shareholder will be forced to take Geng Xing shares or change hands for the fourth time.

　　On January 29th, () announced that 79,929,600 shares held by Zhonggeng Group, the controlling shareholder, would be subject to judicial auction, accounting for 34.71% of the company’s total share capital. This move may lead to the change of the actual controller and controlling shareholder of the company, or it may make the company become an actual controller.

　　This also means that after 7 years of throwing 2 billion yuan into Geng Xing shares, Zhong Geng Group, a Fujian-based housing company, will finally leave. And where will Geng Xing shares, which have changed hands three times since listing and have poor management, go in the future?

　　Facing judicial auction

　　According to the announcement of Geng Xing shares, the company recently learned from the judicial assistance execution platform of Shanghai Stock Exchange and verified by Zhonggeng Group that the Shanghai Financial Court issued the Announcement on Judicial Disposal of Shares on January 26, 2024, which will be publicly handled on the judicial execution platform on February 29, 2024 and March 1, 2024, respectively, and auction 66.6624 million shares of Geng Xing shares held by Zhonggeng Group and 13.2672 million shares.

　　The reason why the above-mentioned shares held by Zhong Geng Group will face judicial disposal auction is because the stock pledge business of Zhong Geng Group is in breach of contract and Xiamen Trust applied for judicial freezing of 66,662,400 shares of Geng Xing shares held by it. Later, because Zhong Geng Group failed to fulfill the ruling made by Xiamen Arbitration Commission on the above-mentioned case, Xiamen Trust applied to Shanghai Financial Court for compulsory execution.

　　In addition, as a guarantor, Zhong Geng Group’s subsidiary was applied by Shanghai Guokun Commercial Factoring Co., Ltd. for judicial freezing of its 13,267,200 shares of Geng Xing’s restricted shares due to disputes over factoring contracts. Later, because Zhong Geng Group failed to fulfill the ruling made by Shanghai Higher People’s Court on the above case, Shanghai Guokun applied to Shanghai Financial Court for compulsory execution.

　　As of the disclosure date of the announcement, Zhonggeng Group holds 81,929,600 shares of listed companies, accounting for 35.57% of the total share capital of listed companies. At present, all its shares are pledged and frozen.

　　Zhonggeng Group was once one of the representatives of Fujian real estate enterprises and was founded in 1997. Since 2006, the company has begun to make a nationwide layout, leaving Fuzhou and marching into Dalian, and then landing in Jiangsu, Beijing, Chongqing and other places. Following the footsteps of Fujian real estate enterprises such as Shimao and Xuhui, Zhonggeng Group moved its headquarters to Shanghai.

　　All the way to expansion, Zhonggeng Group has been squeezed into the top 100. In 2018, Zhonggeng Group’s trading amount reached 23.21 billion yuan, ranking 94th among the national housing enterprises.

　　Zhong Geng Group sought listing for many times, trying to replenish capital through the capital market, but eventually it bought the predecessor of Geng Xing shares, Oriental Silver Star, to achieve listing by curve.

　　Has changed hands three times.

　　Geng Xing shares were once known as Oriental Silver Star and *ST Ice Bear (the predecessor of Oriental Silver Star). Since its listing, it has experienced three changes of ownership, but its operation is still lacking, during which there have been infighting dramas for control rights.

　　The first change of ownership of the company took place in 2005, when Yinxing Zhiye entered the *ST Ice Bear, and then the listed company was renamed Oriental Yinxing. After the reorganization, Oriental Silver Star turned to the real estate industry, but after 2010, the real estate business of Oriental Silver Star came to a standstill.

　　In 2013, after four consecutive placards, Yushang Group gained 20% of the shares of Oriental Silver Star and became the second largest shareholder of the company.

　　The second change of control rights occurred in August 2015. Yinxing Zhiye transferred all the shares of Oriental Yinxing to Jinzhong Dongxin, and completely withdrew. However, during this period, Yushang Group continued to increase its holdings, and there was once a "double-headed board of directors" situation. In October 2016, Jinzhong Dongxin’s shareholding ratio rose to 32%, surpassing Yushang Group, which holds 31% of the shares.

　　In March 2017, the controlling share changed hands for the third time. Jinzhong Dongxin sold its 38,374,400 shares to Zhonggeng Group at a price of 56.03 yuan/share with a premium of 51%, with a total transfer price of 2.15 billion yuan.

　　With the entry of Zhonggeng Group, Oriental Silver Star began to cross the border frequently, but in the end it had little effect, only causing its share price to fluctuate greatly.

　　Oriental Silver Star’s main business was first transformed into a commodity supply chain management business with coal (including coke) as the main business, but the gross profit margin and profitability of this business were generally not high. In 2022, the gross profit margin of this business was only 1.34%.

　　In 2018, Oriental Silver Star planned to purchase 60% equity of Ningbo Zhongkairun in cash through a wholly-owned subsidiary, and then the target was changed to 51% equity of Qifan Investment, which is mainly engaged in investment in real estate-related fields and has invested in real estate projects in Fuzhou. But in the end, the acquisition fell through.

　　In 2021, Oriental Silver Star announced the cross-border semiconductor field, invested 30 million yuan to subscribe for the newly registered capital of Wuhan Minsheng, and held 2.91% equity of Wuhan Minsheng. Wuhan Minsheng is a MEMS manufacturer. In the end, the transformation did not have a big return.

　　On March 20, 2023, Oriental Silver Star changed its name to Geng Xing, and at the same time began a new transformation, announcing its entry into new energy business, mainly operating charging piles and charging stations. However, according to the company’s previously disclosed senior management resume and employee composition, the original team of Geng Xing shares lacked experience in the new energy industry.

　　According to the 2022 annual report, Geng Xing Co., Ltd. has only 37 employees, mainly sales, management and administration personnel, and zero production and technical personnel. According to the semi-annual report of Gengxing in 2023, its new energy vehicle charging business is still in the preparatory stage, and it has not officially opened for operation and generated business income.

　　Business is not good enough.

　　The frequent change of controlling rights and the transformation of main business have not brought actual returns to Geng Xing.

　　In 2021 and 2022, the revenue of Gengxing was 1.612 billion yuan and 1.848 billion yuan respectively, down 40.17% year-on-year and up 14.61%. The net profit was-42.75 million yuan and 16.94 million yuan respectively, down 287% and up 135% respectively.

　　In 2023, the company’s performance showed a "double decline". In the first three quarters of 2023, the company achieved revenue of 484 million yuan, down 70% year-on-year; The net loss was 32.37 million yuan, and the company’s performance turned from profit to loss.

　　Geng Xing shares had previously occupied funds by related parties. In 2022, due to the failure of affiliated companies to arrange payment and delivery settlement as agreed, nearly 170 million yuan of related funds were occupied. The 2022 annual report of Gengxing shares was issued with a qualified audit report by the audit institution.

　　Geng Xing shares said that from 2021 to 2022, the company was occupied by non-operating funds of Zhong Geng Group and its related parties. As of April 26, 2023, the controlling shareholder and its related parties have all returned the above-mentioned non-operating occupied funds and interest.

　　On January 15th, 2024, Geng Xing shares disclosed that it received the Notice of Filing a Case issued by China Securities Regulatory Commission on the same day. The CSRC decided to file a case against the company because the company was suspected of violating laws and regulations in information disclosure.

A few days ago, the pickup truck market obtained the sales data of pickup trucks in the United States in the first half of 2022. In June 2022, the pickup truck market in the United States sold 233,113 new cars, which was 6.9% lower than that of 250,349 in 2021. From January to June, 1,341,611 new cars were sold, down by 11.4% compared with the same period in 2021. Since the global epidemic in COVID-19 in 2020, the pickup truck market in the United States has been affected by factors such as insufficient production capacity and sluggish economy, and its sales volume has declined for two consecutive years. Up to now, it has continued the previous downward trend in 2022, and it is difficult to recover in the short term.

According to statistics, in the first half of 2022,Ford F-series, Ram pickup truck and Chevrolet Sorod still occupy the top three positions, and GMC Sierra surpassed Toyota Tacoma to rise to fourth place; Chevrolet Colorado,Nissan Frontier and GMC CanyonAfter the replacement of medium-sized pickup trucks, the sales performance is remarkable, and emerging pickup trucks such as Ford Maverick and Hyundai Santa Cruz have injected new vitality into the American market; Rivian R1T, Hummer EV and other emerging electric pickup products began to be delivered gradually.

Ford is the absolute overlord of the pickup truck market in the United States, and F-series pickup trucks sell new cars in June.57,673 vehicles, up year on year.26.3%, but even so, it is difficult to hide the overall decline. Only new cars are sold from January to June.299,345 vehicles, a year-on-year decrease of 17.3%. If the overall downward trend cannot be reversed, the annual sales of Ford F-series pickups will probably fall below the 700,000 mark in 2022.The continuous decline in Ford’s sales has also reduced its lead over Chevrolet and Ram, only less than 40,000 vehicles ahead of the second place, and it may be surpassed with a little carelessness. To this end, Ford promptly followed up the electrification reform, and the F-150 Lightning has now won hundreds of thousands of orders.In the future, Ford will maintain its leading position through multi-dimensional development.

In June 2022, Chevrolet Sorod sold a new car.46,313 vehicles, a year-on-year decline.16.7%, selling new cars from January to June.261,827 vehicles, a year-on-year decline.10.1%, also in an endless decline. Chevrolet Sorod completed the update and change in September 2021, focusing onThe interior and configuration have been upgraded and alsoThe ZR2 cross-country performance version of Sorod was introduced.Make it more competitive in the face of the new Ford F-150 and the new Ram 1500. Chevrolet is also keenly aware of the fiery atmosphere of the current electric pickup market, which was released in January 2022.Silverado EV model,The new car is the second pure electric pickup truck product commonly launched after Hummer EV, and it is also built with the brand-new third-generation pure electric platform Ultium Autoenergy platform, which will provide ideas for the next stage upgrade and development of Chevrolet pickup truck models.

2021 is the highlight moment of Ram pickup.Not only is it a rare brand with year-on-year sales growth in the American market, but it also surpassed Chevrolet Sorod to become the second place. However, after entering 2022, Ram failed to resist the overall market decline. In the first half of the year, only 244,984 new cars were sold, down 21.7% compared with the same period of last year, making it the largest decline among the three American giants. Ram launched Ram TRX last year, which was enough to shake the status of the Raptor’s performance pickup truck, which made the Ford F-150 Raptor feel great pressure. Its first electric pickup truck Ram 1500 EV was also scheduled for 2024, which launched an all-round impact on Ford. However, the update speed and range of the conventional Ram 1500 model are obviously insufficient, and the Stellantis brand after integrated management needs to work harder on pickup trucks.

GMC Sierra and Chevrolet Sorod belong to GM.GMC, as a high-end luxury brand of GM, has always focused on top luxury routes, whether it is pickup trucks. Sierra pickupPreviously, it ranked fifth in the sales list all the year round, but this year it surpassed Toyota Tacoma.Sales in the first half of this year were118,938 vehicles, a year-on-year decline.14.1%。GMC SierraUshered in a new generation in October last year.In order to better fight against Ram 1500, it has been upgraded in all directions on the basis of the previous generation, and the top Denali Ultimate and AT4X versions that break through the previous generation have been introduced. GMC Sierra will also launch an electric version in the future, which is developed based on GM’s new Ulitum platform. The specific production time is tentatively set at around 2023.

ToyotaTacoma is the king of medium-sized pickup trucks in the United States, occupying the throne of the sales champion of medium-sized pickup trucks in the United States all the year round, with a sales volume of 108,648 in the first half of 2022.Car,It fell 22% year-on-year. Tacoma is the only "foreign" product that has achieved great success in the United States. It is more popular than its big brother, Toyota Tantu, and the car is currently in a replacement cycle. It is reported that the next generation model will share the R&D platform with 4Runner, brand-new Hilux, brand-new smooth road and brand-new land patrol, so that Toyota products can be better pushed to the global market, so it is not impossible if the new Tacoma production version of the real car is highly similar to the brand-new smooth road in the future. At the same time,Toyota recently announced its electrification development strategy, including an electric pickup truck product, which is supposed to be Tacoma electric version.

Toyota smooth road,Chevrolet Colorado,Nissan Frontier,Jeep gladiator,Ford Maverick,Several models of Ford Ranger constitute the third group. Among them, Toyota, after upgrading, has made remarkable progress. From January to June, it sold 44,316 new cars, up 1% year-on-year, which not only got rid of the previous continuous decline, but also rushed to the position of the leader of the third group. Chevrolet Colorado also has a good performance this year. Thanks to the renewed enthusiasm of consumers for small and medium-sized pickup trucks, the sales volume of the car reached 44,190 from January to June, up 13.7% year-on-year, and the growth rate in June reached 48.4%. Nissan Frontier has also been reborn due to changes in the market wind direction, with sales of 43,168 vehicles in the first half of the year, with a year-on-year increase of 63.6%.

As the saying goes, people’s joys and sorrows are not connected, so are car sales. At present, small and medium-sized pickup trucks have become a hot spot of consumption again. Jeep Gladiator sold 38,756 vehicles in the first half of the year, down 20.6% year-on-year. Perhaps it was abandoned by consumers because of its rich play attributes and low use value. FordMaverick, as a new compact product launched by Ford for market hotspots, well explains the importance of grasping the outlet. The sales volume of new cars in the first half of the year was 38,753, showing a relatively strong growth momentum, and it is expected to become an important sales pillar of Ford pickup trucks in the future. Ford Ranger, once the leader of the third group, fell to the end of the group this year, with sales of only 33,840 vehicles in the first half of the year, down 42% year-on-year. It seems that it will take time for the new Ranger to truly adapt to the American market.

At the bottom of the list isHonda Ridgeline,Modern Santa Cruz,GMC Canyon andNissan Titan, in which Honda Ridgeline’s sales in June this year increased by 5.5% year-on-year, but the cumulative sales from January to June are still in a state of decline; As a pure pickup truck, Hyundai Santa Cruz’s monthly sales are gradually increasing, even surpassing Nissan Titan and GMC Canyon；. GMC Canyon sold 13,662 vehicles in the first half of the year, up 9.4% year-on-year;Nissan Titan sold 11,212 new cars in the first half of the year, down 36.9% year-on-year. It is still in an endless decline. It is reported that Nissan is preparing to give up Titan pickup trucks and there will be no next-generation models.

In 2019, Tesla Cybertruck reshaped pickup products with its subversive design concept, which opened the prelude to competition in the field of electric pickup trucks. Subsequently, Ford F-150 Lightning, Hummer EV, Rivian R1T, Chevrolet Silverado EV and other heavy models came out one after another, which refreshed people’s understanding of electric vehicle products. At present, Hummer EV and Rivian R1T have officially entered the delivery link. Rivian R1T delivered 1,600 new cars in half a year, and Hummer EV delivered 90 vehicles. At present, all major electric pickup truck models have received huge orders, and the main reason that restricts their sales is that the delivery is delayed due to insufficient production capacity.

　　Supreme Leader: Biodiversity is not only the foundation of sustainable development, but also the goal and means. We must use the way of nature to nourish all things, seek development opportunities from the protection of nature, and achieve a win-win situation for ecological and environmental protection and high-quality economic development.

　　This sentence is from the important speech delivered by the Supreme Leader President at the United Nations Biodiversity Summit on September 30, 2020.

　　Biodiversity is the result of billions of years of development and evolution of life on earth, and has important ecological, economic and cultural values for human survival and development. Protecting and restoring biodiversity and improving the diversity, stability and sustainability of ecosystems are conducive to improving our living environment, increasing food and resource supply, and promoting sustainable economic and social development. Conversely, if biodiversity is lost, ecosystems will be out of balance and human survival and development will lose an important foundation.

　　China has a vast territory, land and sea, and has given birth to rich and unique ecosystems, species and genetic diversity. As one of the countries with the richest biodiversity in the world, China has always attached great importance to biodiversity conservation. Especially since the 18th National Congress of the Communist Party of China, under the guidance of the Supreme Leader’s ecological civilization thought, all localities have adhered to ecological priority and green development, and continuously strengthened and innovated biodiversity protection measures.

　　为了保护重要自然生态系统和生物资源，目前，我国把超过30%的陆域国土面积划为生态保护红线，可有效保护90%的陆地生态系统类型和74%的国家重点保护野生动植物种群。经过多年移民搬迁和生态修复，我国设立的第一批5个国家公园有效保护了东北虎、大熊猫等珍稀野生动物及其栖息地，成为万物和谐共生的美好家园。同时，为保护一些濒危物种，我国相继设立国家植物园、野生动物救护繁育基地、种质资源库、基因库等，加大对濒危野生动植物的迁地保护，加强对生物遗传资源的收集保存。为保护候鸟迁徙通道，许多地方加强当地湿地保护，让水草丰茂的栖息地成为候鸟迁徙途中的重要“驿站”。随着生物多样性保护宣传教育和科普活动持续开展，公众参与生物多样性保护的方式更加多元化，参与度全面提高……经过不断探索，我们走出了一条中国特色生物多样性保护之路，各地也在保护自然中逐渐找到适合自身的发展机遇。比如，一些地方在国家公园以外的周边地区发展生态旅游业、林下经济等，让从保护区搬迁出来的当地百姓端上“绿饭碗”，吃上“生态饭”。

　　中国式现代化是人与自然和谐共生的现代化。尊重自然、顺应自然、保护自然，是全面建设社会主义现代化国家的内在要求。新征程上，我们要把生物多样性保护作为生态文明建设重要内容，既总结好已有经验、巩固好已有基础，又不断探索创新保护方式，持续推进生物多样性治理体系和治理能力现代化，进而持续改善自然生态系统状况，提高生态产品供给能力，实现自然生态系统良性循环，不断满足人民日益增长的对优美生态环境需求。

　　本期特约专家：田瑜 中国环境科学研究院生态研究所

Yao Wen (right), special correspondent of Quanzhou Agricultural Science and Technology Xingchuang Tiandi Technology, gave technical guidance to farmers on the prevention and control of pests and diseases of Camellia japonica. Photo by Zhang Peng

　　"Relying on the scientific research achievements resources and talents’ technical advantages of the units where the science and technology commissioners are stationed, we have accelerated the transformation and industrialization of modern agricultural scientific and technological innovations, and hatched and cultivated a number of high-value ’ Agricultural enterprises with high added value. "

　　In Yongchun Zhihui Valley, Xingchuang Tiandi, Fujian Province, Lin Zhirong, a college student, has grown from an entrepreneurial "Xiaobai" who is responsible for the new media promotion of health tea projects to a maker who runs two tea online stores in partnership, realizing a wonderful "turn" in life.

　　This is due to Zhihui Valley’s "helping hand": under the guidance of Zhihui Valley’s entrepreneurial tutor and Associate Professor Zheng Shuangyang of Jiangxia College, with the help of Zhihui Valley platform resources, Lin Zhirong’s project signed a number of tea gardens, and after only six months of operation, it has achieved profitability. In January this year, the turnover of a single store exceeded 100,000 yuan. This is a microcosm of the construction of Xingchuang Tiandi in Quanzhou. Up to now, the city has cultivated 37 star-creation worlds at all levels, including 13 national ones, ranking first in the province in total.

　　"Facing the needs of rural agricultural development in the new era, Quanzhou has played the role of science and technology Commissioner ‘ Mechanism activity ’ , constantly explore new modes of innovative science and technology commissioners’ work, take the lead in extending the service of science and technology commissioners to secondary and tertiary industries in the province, support science and technology commissioners to participate in the construction of Xingchuang Tiandi, accelerate the transformation and industrialization of modern agricultural science and technology innovation achievements by relying on the scientific research resources and talent technology advantages of the units where science and technology commissioners are stationed, and incubate and cultivate a number of ornamental and medicinal plant industries such as Anthurium andraeanum and Cymbidium, with ‘ Gao Yan value ’ Agricultural enterprises with high added value will further promote the innovation and entrepreneurship actions of science and technology commissioners. " Li Wensheng, director of Quanzhou Science and Technology Bureau, said.

　　Build a platform and build an agricultural cooperation exhibition field between Fujian and Taiwan

　　Located in quanzhou taiwanese investment zone, Taiwan Province Agricultural Technology Exchange and Promotion Center, the first national agricultural cooperation and promotion platform between Fujian and Taiwan in China, has exchanged and cooperated with well-known agricultural universities such as Taiwan Province University, Chiayi University and Zhongxing University all the year round; Relying on the construction of Quanzhou Academy of Agricultural Sciences, it is the first to carry out the work of corporate science and technology commissioners in the province, docking high-end resources such as academician workstations, and providing "one-on-one" training and guidance services … … Entering the first batch of national stars to create heaven and earth — — Quanzhou agricultural science and technology star creates a world, and a series of "soft and hard facilities" provided for settled enterprises and makers attract attention.

　　As the earliest enterprise introduced by Xingchuang Tiandi, which specializes in producing ornamental plant Anthurium, Fengquan Agriculture is benefiting from this. "Enterprises connect with Tang Hongling and Zhang Peng through the platform, introduce famous varieties of Anthurium, innovate supporting agricultural facilities, etc., and improve the quantity and quality of finished flowers. The flowering period is extended by 10 to 15 days year-on-year, which effectively improves the competitiveness of enterprise products." Chen Yilong, head of Fengquan Agriculture, said.

　　"By building the platform of Xingchuang Tiandi, we will build a bridge between scientific and technological achievements and makers, which will not only guide innovation and entrepreneurship such as special projects, but also strengthen technical cooperation with settled enterprises, and transform while researching, greatly shortening the agricultural scientific research achievements to ‘ Field ’ Distance, promote the popularization and application of agricultural technology and excellent crop varieties. " Zhuang Weidong, director of Quanzhou Academy of Agricultural Sciences and head of Quanzhou Agricultural Science and Technology Xingcheng Tiandi, said.

　　At present, Xingchuang Tiandi provides services for the whole process of incubation, cultivation and entrepreneurship of agricultural high-tech enterprises nationwide. Under its matchmaking, Fujian Jisheng Pigeon Industry Co., Ltd., a settled enterprise, has reached a cooperation agreement with Taiwan Province Youhui Biotechnology Co., Ltd., in order to further develop the market. Over the past year or so, 15 start-ups have rushed to settle in, and there is an endless stream of incubator seekers.

　　Promote transformation and tap new kinetic energy of characteristic industries

　　Nan ‘anhui Sweet Bee Family Farm, located in Xiangyang Township, Nan ‘an City, Quanzhou, is full of numbered beehives. "You can’t take too much honey in autumn. You should leave enough rations for bees in each box to ensure the survival rate in winter." Under the careful guidance of Professor Zhou Bingfeng of Fujian Agriculture and Forestry University, director of the National Bee Industry Technology System Feeding and Machine Function Research Office of Fujian Agriculture and Rural Affairs Department, the farm has developed and bred 500 colonies of undergrowth bees, with an annual output of 25,000 kilograms of honey and an annual output of 1.5 million yuan. Under-forest beekeeping has also become a characteristic industry to drive local farmers out of poverty and become rich.

　　Previously, as a relatively poor township in Nan ‘an, Xiangyang Township had few agricultural products sales channels, low per capita income and many poor households. Zhou Bingfeng found in the field investigation that the township is surrounded by mountains and the forest coverage rate is as high as 90%, which has a unique advantage in developing bee breeding and bee culture industry. Therefore, Zhou Bingfeng teamed up with Dushan Ecological Agriculture and Forestry Cooperative in Nan ‘an City and Nan ‘an Hui Sweet Bee Family Farm to carry out Industry-University-Research cooperation, and took the lead in creating the first Xingchuang Tiandi focusing on bee entrepreneurship in Fujian — — Huitian Bee Industry has created a new world, promoted the application of new technologies such as large-scale breeding of Chinese bees and healthy and efficient breeding of Chinese bees in the national bee industry technology system, and promoted the improvement of the local Chinese bee breeding technology level and the development and growth of the bee industry.

　　While providing entrepreneurial counseling and incubation services for the bee industry, Xingchuang Tiandi also provided free bee colonies, beehives and breeding technical materials to poor households with established cards, and signed an agreement to purchase bee products, driving 51 poor households to develop bee breeding to get rid of poverty and become rich. Up to now, Huitian Bee Industry Xingchuang Tiandi has settled in 32 agricultural enterprises, successfully hatched 10 enterprises and 44 entrepreneurial teams, including 40 entrepreneurial teams from poor households. The new agricultural business entities cultivated have created economic benefits of 50 million yuan every year.

　　Excavate new kinetic energy from traditional industries and discover new possibilities from emerging industries. In Quanzhou, relying on superior resources, there are many examples of introducing special departments to take the lead in building Xingchuang Tiandi and developing rural characteristic industries. For example, Anxi Tengyun Station Xingchuang Tiandi makes full use of the radiation of Taobao Town and Taobao Village, integrates resources through Xingchuang Tiandi, optimizes the combination of scattered family-owned workshops, promotes the transformation and upgrading of traditional industries, and makes rattan and iron technology production become the leading enterprise and pillar industry in Shangqing Township.

　　Huang Zhenxia, a researcher of Quanzhou Science and Technology Bureau, said that Xingchuang Tiandi has applied modern agricultural concepts to the transformation and upgrading of the whole agricultural industry chain, focused on cultivating new agricultural business entities, supported the development of new industries, new formats and new models, and promoted the development of traditional agriculture to "internet plus" modern agriculture, circular agriculture and leisure agriculture, and has continuously become a new force to promote the transformation and upgrading of Quanzhou’s agriculture.

　　Leading the way, cultivating "new farmers" who strengthen agriculture and promote agriculture

　　"Focus on building a high-quality agricultural science and technology innovation and entrepreneurship service platform. In addition to cultivating college students’ new entrepreneurs, Zhihuigu also supports entrepreneurs such as returning migrant workers and rural youth leaders who become rich, and stimulates more enthusiasm for innovation, entrepreneurship and wealth creation of agriculture-related enterprises." You Changsheng, head of Yongchun Zhihui Valley, said.

　　According to him, at present Zhihui Valley is connected with provincial-level science delegations and associate professor Wang Mingyuan of Huaqiao University, and together with provincial, municipal and county resident cadres in Penghu Town, Yongchun, it has created a "shared poverty alleviation station" to create a shared platform for local agricultural and sideline products to integrate production and marketing, and to change "blood transfusion" poverty alleviation into "hematopoietic" poverty alleviation, helping precision poverty alleviation work.

　　Behind the vitality of Zhihui Guxing’s creation of the world, there is a strong backing, the local leading agricultural enterprise and the demonstration base of Quanzhou science and technology correspondent — — Quanzhou jinsheng ecological agriculture co., ltd. The enterprise built Quanzhou Anoectochilus roxburghii Enterprise Engineering and Technology Research Center, and innovated the techniques of sexual propagation of Anoectochilus roxburghii seedlings and imitation of wild ground cultivation under the forest. Compared with the traditional anoectochilus roxburghii produced by asexual propagation, it is more authentic and has higher nutritional value. The cultivation has driven a group of makers like Lin Zhirong to settle in Zhihui Valley Xingcheng Chuangtiandi.

　　This is another innovative measure of Quanzhou’s layout of Xingchuang Tiandi: make full use of the technical strength of science and technology commissioners, make use of the advantages of capital, manpower, technology, market and management of leading enterprises to build Xingchuang Tiandi, give play to its radiation-driven role, and build a group of "new farmers" who understand agriculture, love the countryside and love farmers, and help win the tough battle against poverty.

　　Li Wensheng said that in the next stage, Quanzhou will take Xingchuang Tiandi as an important starting point for scientific and technological work, promote the seamless connection between the system of science and technology commissioners and encouraging mass entrepreneurship and innovation, further stimulate the vitality of rural innovation and entrepreneurship, build a Xingchuang Tiandi platform suitable for Quanzhou’s development, provide rural science and technology entrepreneurship services for college students and returning migrant workers, promote the integrated development of primary and secondary industries, and drive millions of farmers to increase their income and become rich.

　　It is understood that since 2016, Quanzhou Science and Technology Bureau has gathered 392 entrepreneurial teams, 211 entrepreneurial mentors, served 370 start-ups and held 415 innovative and entrepreneurial activities by cultivating Xingchuang Tiandi. It is planned that by the end of 2020, Quanzhou will strive to cultivate 40 star-creation worlds at all levels and gather 5,000 talents of various scientific and technological innovations, and basically form an agricultural and rural innovation system with popular entrepreneurial subjects, diversified incubation objects, professional entrepreneurial services, networked organizational systems and market-oriented construction and operation. (Reporter Xie Kaifei correspondent Wang Yanshuang Wang Jianping)